                         SEQUENCE LISTING

<110>  Du, Xiaoping
 
<120>  INHIBITORS OF BETA INTEGRIN-G PROTEIN ALPHA SUBUNIT BINDING 
       INTERACTIONS

<130>  27611/45326B PCT

<150>  13/621,064
<151>  2012-09-15

<150>  PCT/US2011/028567
<151>  2011-03-15

<150>  61/314,027
<151>  2010-03-15

<150>  61/433,037
<151>  2011-01-14

<160>  416   

<170>  PatentIn version 3.5

<210>  1
<211>  377
<212>  PRT
<213>  Homo sapiens


<220>
<221>  misc_feature
<223>  G Protein - Alpha 13

<300>
<308>  Genbank / AAH36756
<309>  2006-07-15
<313>  (1)..(377)

<400>  1

Met Ala Asp Phe Leu Pro Ser Arg Ser Val Leu Ser Val Cys Phe Pro 
1               5                   10                  15      


Gly Cys Leu Leu Thr Ser Gly Glu Ala Glu Gln Gln Arg Lys Ser Lys 
            20                  25                  30          


Glu Ile Asp Lys Cys Leu Ser Arg Glu Lys Thr Tyr Val Lys Arg Leu 
        35                  40                  45              


Val Lys Ile Leu Leu Leu Gly Ala Gly Glu Ser Gly Lys Ser Thr Phe 
    50                  55                  60                  


Leu Lys Gln Met Arg Ile Ile His Gly Gln Asp Phe Asp Gln Arg Ala 
65                  70                  75                  80  


Arg Glu Glu Phe Arg Pro Thr Ile Tyr Ser Asn Val Ile Lys Gly Met 
                85                  90                  95      


Arg Val Leu Val Asp Ala Arg Glu Lys Leu His Ile Pro Trp Gly Asp 
            100                 105                 110         


Asn Ser Asn Gln Gln His Gly Asp Lys Met Met Ser Phe Asp Thr Arg 
        115                 120                 125             


Ala Pro Met Ala Ala Gln Gly Met Val Glu Thr Arg Val Phe Leu Gln 
    130                 135                 140                 


Tyr Leu Pro Ala Ile Arg Ala Leu Trp Ala Asp Ser Gly Ile Gln Asn 
145                 150                 155                 160 


Ala Tyr Asp Arg Arg Arg Glu Phe Gln Leu Gly Glu Ser Val Lys Tyr 
                165                 170                 175     


Phe Leu Asp Asn Leu Asp Lys Leu Gly Glu Pro Asp Tyr Ile Pro Ser 
            180                 185                 190         


Gln Gln Asp Ile Leu Leu Ala Arg Arg Pro Thr Lys Gly Ile His Glu 
        195                 200                 205             


Tyr Asp Phe Glu Ile Lys Asn Val Pro Phe Lys Met Val Asp Val Gly 
    210                 215                 220                 


Gly Gln Arg Ser Glu Arg Lys Arg Trp Phe Glu Cys Phe Asp Ser Val 
225                 230                 235                 240 


Thr Ser Ile Leu Phe Leu Val Ser Ser Ser Glu Phe Asp Gln Val Leu 
                245                 250                 255     


Met Glu Asp Arg Leu Thr Asn Arg Leu Thr Glu Ser Leu Asn Ile Phe 
            260                 265                 270         


Glu Thr Ile Val Asn Asn Arg Val Phe Ser Asn Val Ser Ile Ile Leu 
        275                 280                 285             


Phe Leu Asn Lys Thr Asp Leu Leu Glu Glu Lys Val Gln Ile Val Ser 
    290                 295                 300                 


Ile Lys Asp Tyr Phe Leu Glu Phe Glu Gly Asp Pro His Cys Leu Arg 
305                 310                 315                 320 


Asp Val Gln Lys Phe Leu Val Glu Cys Phe Arg Asn Lys Arg Arg Asp 
                325                 330                 335     


Gln Gln Gln Lys Pro Leu Tyr His His Phe Thr Thr Ala Ile Asn Thr 
            340                 345                 350         


Glu Asn Ile Arg Leu Val Phe Arg Asp Val Lys Asp Thr Ile Leu His 
        355                 360                 365             


Asp Asn Leu Lys Gln Leu Met Leu Gln 
    370                 375         


<210>  2
<211>  798
<212>  PRT
<213>  Homo sapiens


<220>
<221>  misc_feature
<223>  Beta-1 integrin

<300>
<308>  Swiss Prot / P05556
<309>  2011-01-11
<313>  (1)..(798)

<400>  2

Met Asn Leu Gln Pro Ile Phe Trp Ile Gly Leu Ile Ser Ser Val Cys 
1               5                   10                  15      


Cys Val Phe Ala Gln Thr Asp Glu Asn Arg Cys Leu Lys Ala Asn Ala 
            20                  25                  30          


Lys Ser Cys Gly Glu Cys Ile Gln Ala Gly Pro Asn Cys Gly Trp Cys 
        35                  40                  45              


Thr Asn Ser Thr Phe Leu Gln Glu Gly Met Pro Thr Ser Ala Arg Cys 
    50                  55                  60                  


Asp Asp Leu Glu Ala Leu Lys Lys Lys Gly Cys Pro Pro Asp Asp Ile 
65                  70                  75                  80  


Glu Asn Pro Arg Gly Ser Lys Asp Ile Lys Lys Asn Lys Asn Val Thr 
                85                  90                  95      


Asn Arg Ser Lys Gly Thr Ala Glu Lys Leu Lys Pro Glu Asp Ile Thr 
            100                 105                 110         


Gln Ile Gln Pro Gln Gln Leu Val Leu Arg Leu Arg Ser Gly Glu Pro 
        115                 120                 125             


Gln Thr Phe Thr Leu Lys Phe Lys Arg Ala Glu Asp Tyr Pro Ile Asp 
    130                 135                 140                 


Leu Tyr Tyr Leu Met Asp Leu Ser Tyr Ser Met Lys Asp Asp Leu Glu 
145                 150                 155                 160 


Asn Val Lys Ser Leu Gly Thr Asp Leu Met Asn Glu Met Arg Arg Ile 
                165                 170                 175     


Thr Ser Asp Phe Arg Ile Gly Phe Gly Ser Phe Val Glu Lys Thr Val 
            180                 185                 190         


Met Pro Tyr Ile Ser Thr Thr Pro Ala Lys Leu Arg Asn Pro Cys Thr 
        195                 200                 205             


Ser Glu Gln Asn Cys Thr Ser Pro Phe Ser Tyr Lys Asn Val Leu Ser 
    210                 215                 220                 


Leu Thr Asn Lys Gly Glu Val Phe Asn Glu Leu Val Gly Lys Gln Arg 
225                 230                 235                 240 


Ile Ser Gly Asn Leu Asp Ser Pro Glu Gly Gly Phe Asp Ala Ile Met 
                245                 250                 255     


Gln Val Ala Val Cys Gly Ser Leu Ile Gly Trp Arg Asn Val Thr Arg 
            260                 265                 270         


Leu Leu Val Phe Ser Thr Asp Ala Gly Phe His Phe Ala Gly Asp Gly 
        275                 280                 285             


Lys Leu Gly Gly Ile Val Leu Pro Asn Asp Gly Gln Cys His Leu Glu 
    290                 295                 300                 


Asn Asn Met Tyr Thr Met Ser His Tyr Tyr Asp Tyr Pro Ser Ile Ala 
305                 310                 315                 320 


His Leu Val Gln Lys Leu Ser Glu Asn Asn Ile Gln Thr Ile Phe Ala 
                325                 330                 335     


Val Thr Glu Glu Phe Gln Pro Val Tyr Lys Glu Leu Lys Asn Leu Ile 
            340                 345                 350         


Pro Lys Ser Ala Val Gly Thr Leu Ser Ala Asn Ser Ser Asn Val Ile 
        355                 360                 365             


Gln Leu Ile Ile Asp Ala Tyr Asn Ser Leu Ser Ser Glu Val Ile Leu 
    370                 375                 380                 


Glu Asn Gly Lys Leu Ser Glu Gly Val Thr Ile Ser Tyr Lys Ser Tyr 
385                 390                 395                 400 


Cys Lys Asn Gly Val Asn Gly Thr Gly Glu Asn Gly Arg Lys Cys Ser 
                405                 410                 415     


Asn Ile Ser Ile Gly Asp Glu Val Gln Phe Glu Ile Ser Ile Thr Ser 
            420                 425                 430         


Asn Lys Cys Pro Lys Lys Asp Ser Asp Ser Phe Lys Ile Arg Pro Leu 
        435                 440                 445             


Gly Phe Thr Glu Glu Val Glu Val Ile Leu Gln Tyr Ile Cys Glu Cys 
    450                 455                 460                 


Glu Cys Gln Ser Glu Gly Ile Pro Glu Ser Pro Lys Cys His Glu Gly 
465                 470                 475                 480 


Asn Gly Thr Phe Glu Cys Gly Ala Cys Arg Cys Asn Glu Gly Arg Val 
                485                 490                 495     


Gly Arg His Cys Glu Cys Ser Thr Asp Glu Val Asn Ser Glu Asp Met 
            500                 505                 510         


Asp Ala Tyr Cys Arg Lys Glu Asn Ser Ser Glu Ile Cys Ser Asn Asn 
        515                 520                 525             


Gly Glu Cys Val Cys Gly Gln Cys Val Cys Arg Lys Arg Asp Asn Thr 
    530                 535                 540                 


Asn Glu Ile Tyr Ser Gly Lys Phe Cys Glu Cys Asp Asn Phe Asn Cys 
545                 550                 555                 560 


Asp Arg Ser Asn Gly Leu Ile Cys Gly Gly Asn Gly Val Cys Lys Cys 
                565                 570                 575     


Arg Val Cys Glu Cys Asn Pro Asn Tyr Thr Gly Ser Ala Cys Asp Cys 
            580                 585                 590         


Ser Leu Asp Thr Ser Thr Cys Glu Ala Ser Asn Gly Gln Ile Cys Asn 
        595                 600                 605             


Gly Arg Gly Ile Cys Glu Cys Gly Val Cys Lys Cys Thr Asp Pro Lys 
    610                 615                 620                 


Phe Gln Gly Gln Thr Cys Glu Met Cys Gln Thr Cys Leu Gly Val Cys 
625                 630                 635                 640 


Ala Glu His Lys Glu Cys Val Gln Cys Arg Ala Phe Asn Lys Gly Glu 
                645                 650                 655     


Lys Lys Asp Thr Cys Thr Gln Glu Cys Ser Tyr Phe Asn Ile Thr Lys 
            660                 665                 670         


Val Glu Ser Arg Asp Lys Leu Pro Gln Pro Val Gln Pro Asp Pro Val 
        675                 680                 685             


Ser His Cys Lys Glu Lys Asp Val Asp Asp Cys Trp Phe Tyr Phe Thr 
    690                 695                 700                 


Tyr Ser Val Asn Gly Asn Asn Glu Val Met Val His Val Val Glu Asn 
705                 710                 715                 720 


Pro Glu Cys Pro Thr Gly Pro Asp Ile Ile Pro Ile Val Ala Gly Val 
                725                 730                 735     


Val Ala Gly Ile Val Leu Ile Gly Leu Ala Leu Leu Leu Ile Trp Lys 
            740                 745                 750         


Leu Leu Met Ile Ile His Asp Arg Arg Glu Phe Ala Lys Phe Glu Lys 
        755                 760                 765             


Glu Lys Met Asn Ala Lys Trp Asp Thr Gly Glu Asn Pro Ile Tyr Lys 
    770                 775                 780                 


Ser Ala Val Thr Thr Val Val Asn Pro Lys Tyr Glu Gly Lys 
785                 790                 795             


<210>  3
<211>  788
<212>  PRT
<213>  Homo sapiens


<220>
<221>  misc_feature
<223>  Beta-3 integrin

<300>
<308>  Swiss Prot / P05106
<309>  2011-01-11
<313>  (1)..(788)

<400>  3

Met Arg Ala Arg Pro Arg Pro Arg Pro Leu Trp Ala Thr Val Leu Ala 
1               5                   10                  15      


Leu Gly Ala Leu Ala Gly Val Gly Val Gly Gly Pro Asn Ile Cys Thr 
            20                  25                  30          


Thr Arg Gly Val Ser Ser Cys Gln Gln Cys Leu Ala Val Ser Pro Met 
        35                  40                  45              


Cys Ala Trp Cys Ser Asp Glu Ala Leu Pro Leu Gly Ser Pro Arg Cys 
    50                  55                  60                  


Asp Leu Lys Glu Asn Leu Leu Lys Asp Asn Cys Ala Pro Glu Ser Ile 
65                  70                  75                  80  


Glu Phe Pro Val Ser Glu Ala Arg Val Leu Glu Asp Arg Pro Leu Ser 
                85                  90                  95      


Asp Lys Gly Ser Gly Asp Ser Ser Gln Val Thr Gln Val Ser Pro Gln 
            100                 105                 110         


Arg Ile Ala Leu Arg Leu Arg Pro Asp Asp Ser Lys Asn Phe Ser Ile 
        115                 120                 125             


Gln Val Arg Gln Val Glu Asp Tyr Pro Val Asp Ile Tyr Tyr Leu Met 
    130                 135                 140                 


Asp Leu Ser Tyr Ser Met Lys Asp Asp Leu Trp Ser Ile Gln Asn Leu 
145                 150                 155                 160 


Gly Thr Lys Leu Ala Thr Gln Met Arg Lys Leu Thr Ser Asn Leu Arg 
                165                 170                 175     


Ile Gly Phe Gly Ala Phe Val Asp Lys Pro Val Ser Pro Tyr Met Tyr 
            180                 185                 190         


Ile Ser Pro Pro Glu Ala Leu Glu Asn Pro Cys Tyr Asp Met Lys Thr 
        195                 200                 205             


Thr Cys Leu Pro Met Phe Gly Tyr Lys His Val Leu Thr Leu Thr Asp 
    210                 215                 220                 


Gln Val Thr Arg Phe Asn Glu Glu Val Lys Lys Gln Ser Val Ser Arg 
225                 230                 235                 240 


Asn Arg Asp Ala Pro Glu Gly Gly Phe Asp Ala Ile Met Gln Ala Thr 
                245                 250                 255     


Val Cys Asp Glu Lys Ile Gly Trp Arg Asn Asp Ala Ser His Leu Leu 
            260                 265                 270         


Val Phe Thr Thr Asp Ala Lys Thr His Ile Ala Leu Asp Gly Arg Leu 
        275                 280                 285             


Ala Gly Ile Val Gln Pro Asn Asp Gly Gln Cys His Val Gly Ser Asp 
    290                 295                 300                 


Asn His Tyr Ser Ala Ser Thr Thr Met Asp Tyr Pro Ser Leu Gly Leu 
305                 310                 315                 320 


Met Thr Glu Lys Leu Ser Gln Lys Asn Ile Asn Leu Ile Phe Ala Val 
                325                 330                 335     


Thr Glu Asn Val Val Asn Leu Tyr Gln Asn Tyr Ser Glu Leu Ile Pro 
            340                 345                 350         


Gly Thr Thr Val Gly Val Leu Ser Met Asp Ser Ser Asn Val Leu Gln 
        355                 360                 365             


Leu Ile Val Asp Ala Tyr Gly Lys Ile Arg Ser Lys Val Glu Leu Glu 
    370                 375                 380                 


Val Arg Asp Leu Pro Glu Glu Leu Ser Leu Ser Phe Asn Ala Thr Cys 
385                 390                 395                 400 


Leu Asn Asn Glu Val Ile Pro Gly Leu Lys Ser Cys Met Gly Leu Lys 
                405                 410                 415     


Ile Gly Asp Thr Val Ser Phe Ser Ile Glu Ala Lys Val Arg Gly Cys 
            420                 425                 430         


Pro Gln Glu Lys Glu Lys Ser Phe Thr Ile Lys Pro Val Gly Phe Lys 
        435                 440                 445             


Asp Ser Leu Ile Val Gln Val Thr Phe Asp Cys Asp Cys Ala Cys Gln 
    450                 455                 460                 


Ala Gln Ala Glu Pro Asn Ser His Arg Cys Asn Asn Gly Asn Gly Thr 
465                 470                 475                 480 


Phe Glu Cys Gly Val Cys Arg Cys Gly Pro Gly Trp Leu Gly Ser Gln 
                485                 490                 495     


Cys Glu Cys Ser Glu Glu Asp Tyr Arg Pro Ser Gln Gln Asp Glu Cys 
            500                 505                 510         


Ser Pro Arg Glu Gly Gln Pro Val Cys Ser Gln Arg Gly Glu Cys Leu 
        515                 520                 525             


Cys Gly Gln Cys Val Cys His Ser Ser Asp Phe Gly Lys Ile Thr Gly 
    530                 535                 540                 


Lys Tyr Cys Glu Cys Asp Asp Phe Ser Cys Val Arg Tyr Lys Gly Glu 
545                 550                 555                 560 


Met Cys Ser Gly His Gly Gln Cys Ser Cys Gly Asp Cys Leu Cys Asp 
                565                 570                 575     


Ser Asp Trp Thr Gly Tyr Tyr Cys Asn Cys Thr Thr Arg Thr Asp Thr 
            580                 585                 590         


Cys Met Ser Ser Asn Gly Leu Leu Cys Ser Gly Arg Gly Lys Cys Glu 
        595                 600                 605             


Cys Gly Ser Cys Val Cys Ile Gln Pro Gly Ser Tyr Gly Asp Thr Cys 
    610                 615                 620                 


Glu Lys Cys Pro Thr Cys Pro Asp Ala Cys Thr Phe Lys Lys Glu Cys 
625                 630                 635                 640 


Val Glu Cys Lys Lys Phe Asp Arg Gly Ala Leu His Asp Glu Asn Thr 
                645                 650                 655     


Cys Asn Arg Tyr Cys Arg Asp Glu Ile Glu Ser Val Lys Glu Leu Lys 
            660                 665                 670         


Asp Thr Gly Lys Asp Ala Val Asn Cys Thr Tyr Lys Asn Glu Asp Asp 
        675                 680                 685             


Cys Val Val Arg Phe Gln Tyr Tyr Glu Asp Ser Ser Gly Lys Ser Ile 
    690                 695                 700                 


Leu Tyr Val Val Glu Glu Pro Glu Cys Pro Lys Gly Pro Asp Ile Leu 
705                 710                 715                 720 


Val Val Leu Leu Ser Val Met Gly Ala Ile Leu Leu Ile Gly Leu Ala 
                725                 730                 735     


Ala Leu Leu Ile Trp Lys Leu Leu Ile Thr Ile His Asp Arg Lys Glu 
            740                 745                 750         


Phe Ala Lys Phe Glu Glu Glu Arg Ala Arg Ala Lys Trp Asp Thr Ala 
        755                 760                 765             


Asn Asn Pro Leu Tyr Lys Glu Ala Thr Ser Thr Phe Thr Asn Ile Thr 
    770                 775                 780                 


Tyr Arg Gly Thr 
785             


<210>  4
<211>  13
<212>  PRT
<213>  Homo sapiens


<220>
<221>  misc_feature
<223>  amino acids 197-209 of G Protein - Alpha 13

<300>
<308>  Genbank / AAH36756
<309>  2006-07-15
<313>  (197)..(209)

<400>  4

Leu Leu Ala Arg Arg Pro Thr Lys Gly Ile His Glu Tyr 
1               5                   10              


<210>  5
<211>  47
<212>  PRT
<213>  Homo sapiens

<300>
<308>  Swiss Prot / P05556
<309>  2011-01-11
<313>  (752)..(798)

<400>  5

Lys Leu Leu Met Ile Ile His Asp Arg Arg Glu Phe Ala Lys Phe Glu 
1               5                   10                  15      


Lys Glu Lys Met Asn Ala Lys Trp Asp Thr Gly Glu Asn Pro Ile Tyr 
            20                  25                  30          


Lys Ser Ala Val Thr Thr Val Val Asn Pro Lys Tyr Glu Gly Lys 
        35                  40                  45          


<210>  6
<211>  47
<212>  PRT
<213>  Homo sapiens


<220>
<221>  misc_feature
<223>  Amino acids 716-762 of Beta-3 integrin

<300>
<308>  Swiss Prot / P05106
<309>  2011-01-11
<313>  (716)..(762)

<400>  6

Gly Pro Asp Ile Leu Val Val Leu Leu Ser Val Met Gly Ala Ile Leu 
1               5                   10                  15      


Leu Ile Gly Leu Ala Ala Leu Leu Ile Trp Lys Leu Leu Ile Thr Ile 
            20                  25                  30          


His Asp Arg Lys Glu Phe Ala Lys Phe Glu Glu Glu Arg Ala Arg 
        35                  40                  45          


<210>  7
<211>  19
<212>  DNA
<213>  Homo sapiens

<400>  7
gtccaccttc ctgaagcag                                                    19


<210>  8
<211>  19
<212>  DNA
<213>  Homo sapiens

<400>  8
ggagatcgac aaatgcctg                                                    19


<210>  9
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (1)..(12)
<223>  Xaa can be any naturally occurring amino acid

<400>  9

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10          


<210>  10
<211>  377
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<223>  G alpha 13 (GenBank Accession # NP_006563.2)

<400>  10

Met Ala Asp Phe Leu Pro Ser Arg Ser Val Leu Ser Val Cys Phe Pro 
1               5                   10                  15      


Gly Cys Leu Leu Thr Ser Gly Glu Ala Glu Gln Gln Arg Lys Ser Lys 
            20                  25                  30          


Glu Ile Asp Lys Cys Leu Ser Arg Glu Lys Thr Tyr Val Lys Arg Leu 
        35                  40                  45              


Val Lys Ile Leu Leu Leu Gly Ala Gly Glu Ser Gly Lys Ser Thr Phe 
    50                  55                  60                  


Leu Lys Gln Met Arg Ile Ile His Gly Gln Asp Phe Asp Gln Arg Ala 
65                  70                  75                  80  


Arg Glu Glu Phe Arg Pro Thr Ile Tyr Ser Asn Val Ile Lys Gly Met 
                85                  90                  95      


Arg Val Leu Val Asp Ala Arg Glu Lys Leu His Ile Pro Trp Gly Asp 
            100                 105                 110         


Asn Ser Asn Gln Gln His Gly Asp Lys Met Met Ser Phe Asp Thr Arg 
        115                 120                 125             


Ala Pro Met Ala Ala Gln Gly Met Val Glu Thr Arg Val Phe Leu Gln 
    130                 135                 140                 


Tyr Leu Pro Ala Ile Arg Ala Leu Trp Ala Asp Ser Gly Ile Gln Asn 
145                 150                 155                 160 


Ala Tyr Asp Arg Arg Arg Glu Phe Gln Leu Gly Glu Ser Val Lys Tyr 
                165                 170                 175     


Phe Leu Asp Asn Leu Asp Lys Leu Gly Glu Pro Asp Tyr Ile Pro Ser 
            180                 185                 190         


Gln Gln Asp Ile Leu Leu Ala Arg Arg Pro Thr Lys Gly Ile His Glu 
        195                 200                 205             


Tyr Asp Phe Glu Ile Lys Asn Val Pro Phe Lys Met Val Asp Val Gly 
    210                 215                 220                 


Gly Gln Arg Ser Glu Arg Lys Arg Trp Phe Glu Cys Phe Asp Ser Val 
225                 230                 235                 240 


Thr Ser Ile Leu Phe Leu Val Ser Ser Ser Glu Phe Asp Gln Val Leu 
                245                 250                 255     


Met Glu Asp Arg Leu Thr Asn Arg Leu Thr Glu Ser Leu Asn Ile Phe 
            260                 265                 270         


Glu Thr Ile Val Asn Asn Arg Val Phe Ser Asn Val Ser Ile Ile Leu 
        275                 280                 285             


Phe Leu Asn Lys Thr Asp Leu Leu Glu Glu Lys Val Gln Ile Val Ser 
    290                 295                 300                 


Ile Lys Asp Tyr Phe Leu Glu Phe Glu Gly Asp Pro His Cys Leu Arg 
305                 310                 315                 320 


Asp Val Gln Lys Phe Leu Val Glu Cys Phe Arg Asn Lys Arg Arg Asp 
                325                 330                 335     


Gln Gln Gln Lys Pro Leu Tyr His His Phe Thr Thr Ala Ile Asn Thr 
            340                 345                 350         


Glu Asn Ile Arg Leu Val Phe Arg Asp Val Lys Asp Thr Ile Leu His 
        355                 360                 365             


Asp Asn Leu Lys Gln Leu Met Leu Gln 
    370                 375         


<210>  11
<211>  381
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<223>  G alpha 12 (GenBank Accession # NP_031379.2)

<400>  11

Met Ser Gly Val Val Arg Thr Leu Ser Arg Cys Leu Leu Pro Ala Glu 
1               5                   10                  15      


Ala Gly Gly Ala Arg Glu Arg Arg Ala Gly Ser Gly Ala Arg Asp Ala 
            20                  25                  30          


Glu Arg Glu Ala Arg Arg Arg Ser Arg Asp Ile Asp Ala Leu Leu Ala 
        35                  40                  45              


Arg Glu Arg Arg Ala Val Arg Arg Leu Val Lys Ile Leu Leu Leu Gly 
    50                  55                  60                  


Ala Gly Glu Ser Gly Lys Ser Thr Phe Leu Lys Gln Met Arg Ile Ile 
65                  70                  75                  80  


His Gly Arg Glu Phe Asp Gln Lys Ala Leu Leu Glu Phe Arg Asp Thr 
                85                  90                  95      


Ile Phe Asp Asn Ile Leu Lys Gly Ser Arg Val Leu Val Asp Ala Arg 
            100                 105                 110         


Asp Lys Leu Gly Ile Pro Trp Gln Tyr Ser Glu Asn Glu Lys His Gly 
        115                 120                 125             


Met Phe Leu Met Ala Phe Glu Asn Lys Ala Gly Leu Pro Val Glu Pro 
    130                 135                 140                 


Ala Thr Phe Gln Leu Tyr Val Pro Ala Leu Ser Ala Leu Trp Arg Asp 
145                 150                 155                 160 


Ser Gly Ile Arg Glu Ala Phe Ser Arg Arg Ser Glu Phe Gln Leu Gly 
                165                 170                 175     


Glu Ser Val Lys Tyr Phe Leu Asp Asn Leu Asp Arg Ile Gly Gln Leu 
            180                 185                 190         


Asn Tyr Phe Pro Ser Lys Gln Asp Ile Leu Leu Ala Arg Lys Ala Thr 
        195                 200                 205             


Lys Gly Ile Val Glu His Asp Phe Val Ile Lys Lys Ile Pro Phe Lys 
    210                 215                 220                 


Met Val Asp Val Gly Gly Gln Arg Ser Gln Arg Gln Lys Trp Phe Gln 
225                 230                 235                 240 


Cys Phe Asp Gly Ile Thr Ser Ile Leu Phe Met Val Ser Ser Ser Glu 
                245                 250                 255     


Tyr Asp Gln Val Leu Met Glu Asp Arg Arg Thr Asn Arg Leu Val Glu 
            260                 265                 270         


Ser Met Asn Ile Phe Glu Thr Ile Val Asn Asn Lys Leu Phe Phe Asn 
        275                 280                 285             


Val Ser Ile Ile Leu Phe Leu Asn Lys Met Asp Leu Leu Val Glu Lys 
    290                 295                 300                 


Val Lys Thr Val Ser Ile Lys Lys His Phe Pro Asp Phe Arg Gly Asp 
305                 310                 315                 320 


Pro His Arg Leu Glu Asp Val Gln Arg Tyr Leu Val Gln Cys Phe Asp 
                325                 330                 335     


Arg Lys Arg Arg Asn Arg Ser Lys Pro Leu Phe His His Phe Thr Thr 
            340                 345                 350         


Ala Ile Asp Thr Glu Asn Val Arg Phe Val Phe His Ala Val Lys Asp 
        355                 360                 365             


Thr Ile Leu Gln Glu Asn Leu Lys Asp Ile Met Leu Gln 
    370                 375                 380     


<210>  12
<211>  778
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<223>  Beta 1A integrin (GenBank Accession No. NP_002202)

<400>  12

Gln Thr Asp Glu Asn Arg Cys Leu Lys Ala Asn Ala Lys Ser Cys Gly 
1               5                   10                  15      


Glu Cys Ile Gln Ala Gly Pro Asn Cys Gly Trp Cys Thr Asn Ser Thr 
            20                  25                  30          


Phe Leu Gln Glu Gly Met Pro Thr Ser Ala Arg Cys Asp Asp Leu Glu 
        35                  40                  45              


Ala Leu Lys Lys Lys Gly Cys Pro Pro Asp Asp Ile Glu Asn Pro Arg 
    50                  55                  60                  


Gly Ser Lys Asp Ile Lys Lys Asn Lys Asn Val Thr Asn Arg Ser Lys 
65                  70                  75                  80  


Gly Thr Ala Glu Lys Leu Lys Pro Glu Asp Ile Thr Gln Ile Gln Pro 
                85                  90                  95      


Gln Gln Leu Val Leu Arg Leu Arg Ser Gly Glu Pro Gln Thr Phe Thr 
            100                 105                 110         


Leu Lys Phe Lys Arg Ala Glu Asp Tyr Pro Ile Asp Leu Tyr Tyr Leu 
        115                 120                 125             


Met Asp Leu Ser Tyr Ser Met Lys Asp Asp Leu Glu Asn Val Lys Ser 
    130                 135                 140                 


Leu Gly Thr Asp Leu Met Asn Glu Met Arg Arg Ile Thr Ser Asp Phe 
145                 150                 155                 160 


Arg Ile Gly Phe Gly Ser Phe Val Glu Lys Thr Val Met Pro Tyr Ile 
                165                 170                 175     


Ser Thr Thr Pro Ala Lys Leu Arg Asn Pro Cys Thr Ser Glu Gln Asn 
            180                 185                 190         


Cys Thr Ser Pro Phe Ser Tyr Lys Asn Val Leu Ser Leu Thr Asn Lys 
        195                 200                 205             


Gly Glu Val Phe Asn Glu Leu Val Gly Lys Gln Arg Ile Ser Gly Asn 
    210                 215                 220                 


Leu Asp Ser Pro Glu Gly Gly Phe Asp Ala Ile Met Gln Val Ala Val 
225                 230                 235                 240 


Cys Gly Ser Leu Ile Gly Trp Arg Asn Val Thr Arg Leu Leu Val Phe 
                245                 250                 255     


Ser Thr Asp Ala Gly Phe His Phe Ala Gly Asp Gly Lys Leu Gly Gly 
            260                 265                 270         


Ile Val Leu Pro Asn Asp Gly Gln Cys His Leu Glu Asn Asn Met Tyr 
        275                 280                 285             


Thr Met Ser His Tyr Tyr Asp Tyr Pro Ser Ile Ala His Leu Val Gln 
    290                 295                 300                 


Lys Leu Ser Glu Asn Asn Ile Gln Thr Ile Phe Ala Val Thr Glu Glu 
305                 310                 315                 320 


Phe Gln Pro Val Tyr Lys Glu Leu Lys Asn Leu Ile Pro Lys Ser Ala 
                325                 330                 335     


Val Gly Thr Leu Ser Ala Asn Ser Ser Asn Val Ile Gln Leu Ile Ile 
            340                 345                 350         


Asp Ala Tyr Asn Ser Leu Ser Ser Glu Val Ile Leu Glu Asn Gly Lys 
        355                 360                 365             


Leu Ser Glu Gly Val Thr Ile Ser Tyr Lys Ser Tyr Cys Lys Asn Gly 
    370                 375                 380                 


Val Asn Gly Thr Gly Glu Asn Gly Arg Lys Cys Ser Asn Ile Ser Ile 
385                 390                 395                 400 


Gly Asp Glu Val Gln Phe Glu Ile Ser Ile Thr Ser Asn Lys Cys Pro 
                405                 410                 415     


Lys Lys Asp Ser Asp Ser Phe Lys Ile Arg Pro Leu Gly Phe Thr Glu 
            420                 425                 430         


Glu Val Glu Val Ile Leu Gln Tyr Ile Cys Glu Cys Glu Cys Gln Ser 
        435                 440                 445             


Glu Gly Ile Pro Glu Ser Pro Lys Cys His Glu Gly Asn Gly Thr Phe 
    450                 455                 460                 


Glu Cys Gly Ala Cys Arg Cys Asn Glu Gly Arg Val Gly Arg His Cys 
465                 470                 475                 480 


Glu Cys Ser Thr Asp Glu Val Asn Ser Glu Asp Met Asp Ala Tyr Cys 
                485                 490                 495     


Arg Lys Glu Asn Ser Ser Glu Ile Cys Ser Asn Asn Gly Glu Cys Val 
            500                 505                 510         


Cys Gly Gln Cys Val Cys Arg Lys Arg Asp Asn Thr Asn Glu Ile Tyr 
        515                 520                 525             


Ser Gly Lys Phe Cys Glu Cys Asp Asn Phe Asn Cys Asp Arg Ser Asn 
    530                 535                 540                 


Gly Leu Ile Cys Gly Gly Asn Gly Val Cys Lys Cys Arg Val Cys Glu 
545                 550                 555                 560 


Cys Asn Pro Asn Tyr Thr Gly Ser Ala Cys Asp Cys Ser Leu Asp Thr 
                565                 570                 575     


Ser Thr Cys Glu Ala Ser Asn Gly Gln Ile Cys Asn Gly Arg Gly Ile 
            580                 585                 590         


Cys Glu Cys Gly Val Cys Lys Cys Thr Asp Pro Lys Phe Gln Gly Gln 
        595                 600                 605             


Thr Cys Glu Met Cys Gln Thr Cys Leu Gly Val Cys Ala Glu His Lys 
    610                 615                 620                 


Glu Cys Val Gln Cys Arg Ala Phe Asn Lys Gly Glu Lys Lys Asp Thr 
625                 630                 635                 640 


Cys Thr Gln Glu Cys Ser Tyr Phe Asn Ile Thr Lys Val Glu Ser Arg 
                645                 650                 655     


Asp Lys Leu Pro Gln Pro Val Gln Pro Asp Pro Val Ser His Cys Lys 
            660                 665                 670         


Glu Lys Asp Val Asp Asp Cys Trp Phe Tyr Phe Thr Tyr Ser Val Asn 
        675                 680                 685             


Gly Asn Asn Glu Val Met Val His Val Val Glu Asn Pro Glu Cys Pro 
    690                 695                 700                 


Thr Gly Pro Asp Ile Ile Pro Ile Val Ala Gly Val Val Ala Gly Ile 
705                 710                 715                 720 


Val Leu Ile Gly Leu Ala Leu Leu Leu Ile Trp Lys Leu Leu Met Ile 
                725                 730                 735     


Ile His Asp Arg Arg Glu Phe Ala Lys Phe Glu Lys Glu Lys Met Asn 
            740                 745                 750         


Ala Lys Trp Asp Thr Gly Glu Asn Pro Ile Tyr Lys Ser Ala Val Thr 
        755                 760                 765             


Thr Val Val Asn Pro Lys Tyr Glu Gly Lys 
    770                 775             


<210>  13
<211>  781
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<223>  Beta 1D integrin (GenBank Accession No. NP_391988)

<400>  13

Gln Thr Asp Glu Asn Arg Cys Leu Lys Ala Asn Ala Lys Ser Cys Gly 
1               5                   10                  15      


Glu Cys Ile Gln Ala Gly Pro Asn Cys Gly Trp Cys Thr Asn Ser Thr 
            20                  25                  30          


Phe Leu Gln Glu Gly Met Pro Thr Ser Ala Arg Cys Asp Asp Leu Glu 
        35                  40                  45              


Ala Leu Lys Lys Lys Gly Cys Pro Pro Asp Asp Ile Glu Asn Pro Arg 
    50                  55                  60                  


Gly Ser Lys Asp Ile Lys Lys Asn Lys Asn Val Thr Asn Arg Ser Lys 
65                  70                  75                  80  


Gly Thr Ala Glu Lys Leu Lys Pro Glu Asp Ile Thr Gln Ile Gln Pro 
                85                  90                  95      


Gln Gln Leu Val Leu Arg Leu Arg Ser Gly Glu Pro Gln Thr Phe Thr 
            100                 105                 110         


Leu Lys Phe Lys Arg Ala Glu Asp Tyr Pro Ile Asp Leu Tyr Tyr Leu 
        115                 120                 125             


Met Asp Leu Ser Tyr Ser Met Lys Asp Asp Leu Glu Asn Val Lys Ser 
    130                 135                 140                 


Leu Gly Thr Asp Leu Met Asn Glu Met Arg Arg Ile Thr Ser Asp Phe 
145                 150                 155                 160 


Arg Ile Gly Phe Gly Ser Phe Val Glu Lys Thr Val Met Pro Tyr Ile 
                165                 170                 175     


Ser Thr Thr Pro Ala Lys Leu Arg Asn Pro Cys Thr Ser Glu Gln Asn 
            180                 185                 190         


Cys Thr Ser Pro Phe Ser Tyr Lys Asn Val Leu Ser Leu Thr Asn Lys 
        195                 200                 205             


Gly Glu Val Phe Asn Glu Leu Val Gly Lys Gln Arg Ile Ser Gly Asn 
    210                 215                 220                 


Leu Asp Ser Pro Glu Gly Gly Phe Asp Ala Ile Met Gln Val Ala Val 
225                 230                 235                 240 


Cys Gly Ser Leu Ile Gly Trp Arg Asn Val Thr Arg Leu Leu Val Phe 
                245                 250                 255     


Ser Thr Asp Ala Gly Phe His Phe Ala Gly Asp Gly Lys Leu Gly Gly 
            260                 265                 270         


Ile Val Leu Pro Asn Asp Gly Gln Cys His Leu Glu Asn Asn Met Tyr 
        275                 280                 285             


Thr Met Ser His Tyr Tyr Asp Tyr Pro Ser Ile Ala His Leu Val Gln 
    290                 295                 300                 


Lys Leu Ser Glu Asn Asn Ile Gln Thr Ile Phe Ala Val Thr Glu Glu 
305                 310                 315                 320 


Phe Gln Pro Val Tyr Lys Glu Leu Lys Asn Leu Ile Pro Lys Ser Ala 
                325                 330                 335     


Val Gly Thr Leu Ser Ala Asn Ser Ser Asn Val Ile Gln Leu Ile Ile 
            340                 345                 350         


Asp Ala Tyr Asn Ser Leu Ser Ser Glu Val Ile Leu Glu Asn Gly Lys 
        355                 360                 365             


Leu Ser Glu Gly Val Thr Ile Ser Tyr Lys Ser Tyr Cys Lys Asn Gly 
    370                 375                 380                 


Val Asn Gly Thr Gly Glu Asn Gly Arg Lys Cys Ser Asn Ile Ser Ile 
385                 390                 395                 400 


Gly Asp Glu Val Gln Phe Glu Ile Ser Ile Thr Ser Asn Lys Cys Pro 
                405                 410                 415     


Lys Lys Asp Ser Asp Ser Phe Lys Ile Arg Pro Leu Gly Phe Thr Glu 
            420                 425                 430         


Glu Val Glu Val Ile Leu Gln Tyr Ile Cys Glu Cys Glu Cys Gln Ser 
        435                 440                 445             


Glu Gly Ile Pro Glu Ser Pro Lys Cys His Glu Gly Asn Gly Thr Phe 
    450                 455                 460                 


Glu Cys Gly Ala Cys Arg Cys Asn Glu Gly Arg Val Gly Arg His Cys 
465                 470                 475                 480 


Glu Cys Ser Thr Asp Glu Val Asn Ser Glu Asp Met Asp Ala Tyr Cys 
                485                 490                 495     


Arg Lys Glu Asn Ser Ser Glu Ile Cys Ser Asn Asn Gly Glu Cys Val 
            500                 505                 510         


Cys Gly Gln Cys Val Cys Arg Lys Arg Asp Asn Thr Asn Glu Ile Tyr 
        515                 520                 525             


Ser Gly Lys Phe Cys Glu Cys Asp Asn Phe Asn Cys Asp Arg Ser Asn 
    530                 535                 540                 


Gly Leu Ile Cys Gly Gly Asn Gly Val Cys Lys Cys Arg Val Cys Glu 
545                 550                 555                 560 


Cys Asn Pro Asn Tyr Thr Gly Ser Ala Cys Asp Cys Ser Leu Asp Thr 
                565                 570                 575     


Ser Thr Cys Glu Ala Ser Asn Gly Gln Ile Cys Asn Gly Arg Gly Ile 
            580                 585                 590         


Cys Glu Cys Gly Val Cys Lys Cys Thr Asp Pro Lys Phe Gln Gly Gln 
        595                 600                 605             


Thr Cys Glu Met Cys Gln Thr Cys Leu Gly Val Cys Ala Glu His Lys 
    610                 615                 620                 


Glu Cys Val Gln Cys Arg Ala Phe Asn Lys Gly Glu Lys Lys Asp Thr 
625                 630                 635                 640 


Cys Thr Gln Glu Cys Ser Tyr Phe Asn Ile Thr Lys Val Glu Ser Arg 
                645                 650                 655     


Asp Lys Leu Pro Gln Pro Val Gln Pro Asp Pro Val Ser His Cys Lys 
            660                 665                 670         


Glu Lys Asp Val Asp Asp Cys Trp Phe Tyr Phe Thr Tyr Ser Val Asn 
        675                 680                 685             


Gly Asn Asn Glu Val Met Val His Val Val Glu Asn Pro Glu Cys Pro 
    690                 695                 700                 


Thr Gly Pro Asp Ile Ile Pro Ile Val Ala Gly Val Val Ala Gly Ile 
705                 710                 715                 720 


Val Leu Ile Gly Leu Ala Leu Leu Leu Ile Trp Lys Leu Leu Met Ile 
                725                 730                 735     


Ile His Asp Arg Arg Glu Phe Ala Lys Phe Glu Lys Glu Lys Met Asn 
            740                 745                 750         


Ala Lys Trp Asp Thr Gln Glu Asn Pro Ile Tyr Lys Ser Pro Ile Asn 
        755                 760                 765             


Asn Phe Lys Asn Pro Asn Tyr Gly Arg Lys Ala Gly Leu 
    770                 775                 780     


<210>  14
<211>  747
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<223>  Beta 2 integrin (GenBank Accession NP_000202)

<400>  14

Gln Glu Cys Thr Lys Phe Lys Val Ser Ser Cys Arg Glu Cys Ile Glu 
1               5                   10                  15      


Ser Gly Pro Gly Cys Thr Trp Cys Gln Lys Leu Asn Phe Thr Gly Pro 
            20                  25                  30          


Gly Asp Pro Asp Ser Ile Arg Cys Asp Thr Arg Pro Gln Leu Leu Met 
        35                  40                  45              


Arg Gly Cys Ala Ala Asp Asp Ile Met Asp Pro Thr Ser Leu Ala Glu 
    50                  55                  60                  


Thr Gln Glu Asp His Asn Gly Gly Gln Lys Gln Leu Ser Pro Gln Lys 
65                  70                  75                  80  


Val Thr Leu Tyr Leu Arg Pro Gly Gln Ala Ala Ala Phe Asn Val Thr 
                85                  90                  95      


Phe Arg Arg Ala Lys Gly Tyr Pro Ile Asp Leu Tyr Tyr Leu Met Asp 
            100                 105                 110         


Leu Ser Tyr Ser Met Leu Asp Asp Leu Arg Asn Val Lys Lys Leu Gly 
        115                 120                 125             


Gly Asp Leu Leu Arg Ala Leu Asn Glu Ile Thr Glu Ser Gly Arg Ile 
    130                 135                 140                 


Gly Phe Gly Ser Phe Val Asp Lys Thr Val Leu Pro Phe Val Asn Thr 
145                 150                 155                 160 


His Pro Asp Lys Leu Arg Asn Pro Cys Pro Asn Lys Glu Lys Glu Cys 
                165                 170                 175     


Gln Pro Pro Phe Ala Phe Arg His Val Leu Lys Leu Thr Asn Asn Ser 
            180                 185                 190         


Asn Gln Phe Gln Thr Glu Val Gly Lys Gln Leu Ile Ser Gly Asn Leu 
        195                 200                 205             


Asp Ala Pro Glu Gly Gly Leu Asp Ala Met Met Gln Val Ala Ala Cys 
    210                 215                 220                 


Pro Glu Glu Ile Gly Trp Arg Asn Val Thr Arg Leu Leu Val Phe Ala 
225                 230                 235                 240 


Thr Asp Asp Gly Phe His Phe Ala Gly Asp Gly Lys Leu Gly Ala Ile 
                245                 250                 255     


Leu Thr Pro Asn Asp Gly Arg Cys His Leu Glu Asp Asn Leu Tyr Lys 
            260                 265                 270         


Arg Ser Asn Glu Phe Asp Tyr Pro Ser Val Gly Gln Leu Ala His Lys 
        275                 280                 285             


Leu Ala Glu Asn Asn Ile Gln Pro Ile Phe Ala Val Thr Ser Arg Met 
    290                 295                 300                 


Val Lys Thr Tyr Glu Lys Leu Thr Glu Ile Ile Pro Lys Ser Ala Val 
305                 310                 315                 320 


Gly Glu Leu Ser Glu Asp Ser Ser Asn Val Val Gln Leu Ile Lys Asn 
                325                 330                 335     


Ala Tyr Asn Lys Leu Ser Ser Arg Val Phe Leu Asp His Asn Ala Leu 
            340                 345                 350         


Pro Asp Thr Leu Lys Val Thr Tyr Asp Ser Phe Cys Ser Asn Gly Val 
        355                 360                 365             


Thr His Arg Asn Gln Pro Arg Gly Asp Cys Asp Gly Val Gln Ile Asn 
    370                 375                 380                 


Val Pro Ile Thr Phe Gln Val Lys Val Thr Ala Thr Glu Cys Ile Gln 
385                 390                 395                 400 


Glu Gln Ser Phe Val Ile Arg Ala Leu Gly Phe Thr Asp Ile Val Thr 
                405                 410                 415     


Val Gln Val Leu Pro Gln Cys Glu Cys Arg Cys Arg Asp Gln Ser Arg 
            420                 425                 430         


Asp Arg Ser Leu Cys His Gly Lys Gly Phe Leu Glu Cys Gly Ile Cys 
        435                 440                 445             


Arg Cys Asp Thr Gly Tyr Ile Gly Lys Asn Cys Glu Cys Gln Thr Gln 
    450                 455                 460                 


Gly Arg Ser Ser Gln Glu Leu Glu Gly Ser Cys Arg Lys Asp Asn Asn 
465                 470                 475                 480 


Ser Ile Ile Cys Ser Gly Leu Gly Asp Cys Val Cys Gly Gln Cys Leu 
                485                 490                 495     


Cys His Thr Ser Asp Val Pro Gly Lys Leu Ile Tyr Gly Gln Tyr Cys 
            500                 505                 510         


Glu Cys Asp Thr Ile Asn Cys Glu Arg Tyr Asn Gly Gln Val Cys Gly 
        515                 520                 525             


Gly Pro Gly Arg Gly Leu Cys Phe Cys Gly Lys Cys Arg Cys His Pro 
    530                 535                 540                 


Gly Phe Glu Gly Ser Ala Cys Gln Cys Glu Arg Thr Thr Glu Gly Cys 
545                 550                 555                 560 


Leu Asn Pro Arg Arg Val Glu Cys Ser Gly Arg Gly Arg Cys Arg Cys 
                565                 570                 575     


Asn Val Cys Glu Cys His Ser Gly Tyr Gln Leu Pro Leu Cys Gln Glu 
            580                 585                 590         


Cys Pro Gly Cys Pro Ser Pro Cys Gly Lys Tyr Ile Ser Cys Ala Glu 
        595                 600                 605             


Cys Leu Lys Phe Glu Lys Gly Pro Phe Gly Lys Asn Cys Ser Ala Ala 
    610                 615                 620                 


Cys Pro Gly Leu Gln Leu Ser Asn Asn Pro Val Lys Gly Arg Thr Cys 
625                 630                 635                 640 


Lys Glu Arg Asp Ser Glu Gly Cys Trp Val Ala Tyr Thr Leu Glu Gln 
                645                 650                 655     


Gln Asp Gly Met Asp Arg Tyr Leu Ile Tyr Val Asp Glu Ser Arg Glu 
            660                 665                 670         


Cys Val Ala Gly Pro Asn Ile Ala Ala Ile Val Gly Gly Thr Val Ala 
        675                 680                 685             


Gly Ile Val Leu Ile Gly Ile Leu Leu Leu Val Ile Trp Lys Ala Leu 
    690                 695                 700                 


Ile His Leu Ser Asp Leu Arg Glu Tyr Arg Arg Phe Glu Lys Glu Lys 
705                 710                 715                 720 


Leu Lys Ser Gln Trp Asn Asn Asp Asn Pro Leu Phe Lys Ser Ala Thr 
                725                 730                 735     


Thr Thr Val Met Asn Pro Lys Phe Ala Glu Ser 
            740                 745         


<210>  15
<211>  762
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<223>  Beta 3 integrin (GenBank Accession No. NP_000203)

<400>  15

Gly Pro Asn Ile Cys Thr Thr Arg Gly Val Ser Ser Cys Gln Gln Cys 
1               5                   10                  15      


Leu Ala Val Ser Pro Met Cys Ala Trp Cys Ser Asp Glu Ala Leu Pro 
            20                  25                  30          


Leu Gly Ser Pro Arg Cys Asp Leu Lys Glu Asn Leu Leu Lys Asp Asn 
        35                  40                  45              


Cys Ala Pro Glu Ser Ile Glu Phe Pro Val Ser Glu Ala Arg Val Leu 
    50                  55                  60                  


Glu Asp Arg Pro Leu Ser Asp Lys Gly Ser Gly Asp Ser Ser Gln Val 
65                  70                  75                  80  


Thr Gln Val Ser Pro Gln Arg Ile Ala Leu Arg Leu Arg Pro Asp Asp 
                85                  90                  95      


Ser Lys Asn Phe Ser Ile Gln Val Arg Gln Val Glu Asp Tyr Pro Val 
            100                 105                 110         


Asp Ile Tyr Tyr Leu Met Asp Leu Ser Tyr Ser Met Lys Asp Asp Leu 
        115                 120                 125             


Trp Ser Ile Gln Asn Leu Gly Thr Lys Leu Ala Thr Gln Met Arg Lys 
    130                 135                 140                 


Leu Thr Ser Asn Leu Arg Ile Gly Phe Gly Ala Phe Val Asp Lys Pro 
145                 150                 155                 160 


Val Ser Pro Tyr Met Tyr Ile Ser Pro Pro Glu Ala Leu Glu Asn Pro 
                165                 170                 175     


Cys Tyr Asp Met Lys Thr Thr Cys Leu Pro Met Phe Gly Tyr Lys His 
            180                 185                 190         


Val Leu Thr Leu Thr Asp Gln Val Thr Arg Phe Asn Glu Glu Val Lys 
        195                 200                 205             


Lys Gln Ser Val Ser Arg Asn Arg Asp Ala Pro Glu Gly Gly Phe Asp 
    210                 215                 220                 


Ala Ile Met Gln Ala Thr Val Cys Asp Glu Lys Ile Gly Trp Arg Asn 
225                 230                 235                 240 


Asp Ala Ser His Leu Leu Val Phe Thr Thr Asp Ala Lys Thr His Ile 
                245                 250                 255     


Ala Leu Asp Gly Arg Leu Ala Gly Ile Val Gln Pro Asn Asp Gly Gln 
            260                 265                 270         


Cys His Val Gly Ser Asp Asn His Tyr Ser Ala Ser Thr Thr Met Asp 
        275                 280                 285             


Tyr Pro Ser Leu Gly Leu Met Thr Glu Lys Leu Ser Gln Lys Asn Ile 
    290                 295                 300                 


Asn Leu Ile Phe Ala Val Thr Glu Asn Val Val Asn Leu Tyr Gln Asn 
305                 310                 315                 320 


Tyr Ser Glu Leu Ile Pro Gly Thr Thr Val Gly Val Leu Ser Met Asp 
                325                 330                 335     


Ser Ser Asn Val Leu Gln Leu Ile Val Asp Ala Tyr Gly Lys Ile Arg 
            340                 345                 350         


Ser Lys Val Glu Leu Glu Val Arg Asp Leu Pro Glu Glu Leu Ser Leu 
        355                 360                 365             


Ser Phe Asn Ala Thr Cys Leu Asn Asn Glu Val Ile Pro Gly Leu Lys 
    370                 375                 380                 


Ser Cys Met Gly Leu Lys Ile Gly Asp Thr Val Ser Phe Ser Ile Glu 
385                 390                 395                 400 


Ala Lys Val Arg Gly Cys Pro Gln Glu Lys Glu Lys Ser Phe Thr Ile 
                405                 410                 415     


Lys Pro Val Gly Phe Lys Asp Ser Leu Ile Val Gln Val Thr Phe Asp 
            420                 425                 430         


Cys Asp Cys Ala Cys Gln Ala Gln Ala Glu Pro Asn Ser His Arg Cys 
        435                 440                 445             


Asn Asn Gly Asn Gly Thr Phe Glu Cys Gly Val Cys Arg Cys Gly Pro 
    450                 455                 460                 


Gly Trp Leu Gly Ser Gln Cys Glu Cys Ser Glu Glu Asp Tyr Arg Pro 
465                 470                 475                 480 


Ser Gln Gln Asp Glu Cys Ser Pro Arg Glu Gly Gln Pro Val Cys Ser 
                485                 490                 495     


Gln Arg Gly Glu Cys Leu Cys Gly Gln Cys Val Cys His Ser Ser Asp 
            500                 505                 510         


Phe Gly Lys Ile Thr Gly Lys Tyr Cys Glu Cys Asp Asp Phe Ser Cys 
        515                 520                 525             


Val Arg Tyr Lys Gly Glu Met Cys Ser Gly His Gly Gln Cys Ser Cys 
    530                 535                 540                 


Gly Asp Cys Leu Cys Asp Ser Asp Trp Thr Gly Tyr Tyr Cys Asn Cys 
545                 550                 555                 560 


Thr Thr Arg Thr Asp Thr Cys Met Ser Ser Asn Gly Leu Leu Cys Ser 
                565                 570                 575     


Gly Arg Gly Lys Cys Glu Cys Gly Ser Cys Val Cys Ile Gln Pro Gly 
            580                 585                 590         


Ser Tyr Gly Asp Thr Cys Glu Lys Cys Pro Thr Cys Pro Asp Ala Cys 
        595                 600                 605             


Thr Phe Lys Lys Glu Cys Val Glu Cys Lys Lys Phe Asp Arg Gly Ala 
    610                 615                 620                 


Leu His Asp Glu Asn Thr Cys Asn Arg Tyr Cys Arg Asp Glu Ile Glu 
625                 630                 635                 640 


Ser Val Lys Glu Leu Lys Asp Thr Gly Lys Asp Ala Val Asn Cys Thr 
                645                 650                 655     


Tyr Lys Asn Glu Asp Asp Cys Val Val Arg Phe Gln Tyr Tyr Glu Asp 
            660                 665                 670         


Ser Ser Gly Lys Ser Ile Leu Tyr Val Val Glu Glu Pro Glu Cys Pro 
        675                 680                 685             


Lys Gly Pro Asp Ile Leu Val Val Leu Leu Ser Val Met Gly Ala Ile 
    690                 695                 700                 


Leu Leu Ile Gly Leu Ala Ala Leu Leu Ile Trp Lys Leu Leu Ile Thr 
705                 710                 715                 720 


Ile His Asp Arg Lys Glu Phe Ala Lys Phe Glu Glu Glu Arg Ala Arg 
                725                 730                 735     


Ala Lys Trp Asp Thr Ala Asn Asn Pro Leu Tyr Lys Glu Ala Thr Ser 
            740                 745                 750         


Thr Phe Thr Asn Ile Thr Tyr Arg Gly Thr 
        755                 760         


<210>  16
<211>  776
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<223>  Beta 5 integrin (GenBank Accession No. NP_002204.2)

<400>  16

Gly Leu Asn Ile Cys Thr Ser Gly Ser Ala Thr Ser Cys Glu Glu Cys 
1               5                   10                  15      


Leu Leu Ile His Pro Lys Cys Ala Trp Cys Ser Lys Glu Asp Phe Gly 
            20                  25                  30          


Ser Pro Arg Ser Ile Thr Ser Arg Cys Asp Leu Arg Ala Asn Leu Val 
        35                  40                  45              


Lys Asn Gly Cys Gly Gly Glu Ile Glu Ser Pro Ala Ser Ser Phe His 
    50                  55                  60                  


Val Leu Arg Ser Leu Pro Leu Ser Ser Lys Gly Ser Gly Ser Ala Gly 
65                  70                  75                  80  


Trp Asp Val Ile Gln Met Thr Pro Gln Glu Ile Ala Val Asn Leu Arg 
                85                  90                  95      


Pro Gly Asp Lys Thr Thr Phe Gln Leu Gln Val Arg Gln Val Glu Asp 
            100                 105                 110         


Tyr Pro Val Asp Leu Tyr Tyr Leu Met Asp Leu Ser Leu Ser Met Lys 
        115                 120                 125             


Asp Asp Leu Asp Asn Ile Arg Ser Leu Gly Thr Lys Leu Ala Glu Glu 
    130                 135                 140                 


Met Arg Lys Leu Thr Ser Asn Phe Arg Leu Gly Phe Gly Ser Phe Val 
145                 150                 155                 160 


Asp Lys Asp Ile Ser Pro Phe Ser Tyr Thr Ala Pro Arg Tyr Gln Thr 
                165                 170                 175     


Asn Pro Cys Ile Gly Tyr Lys Leu Phe Pro Asn Cys Val Pro Ser Phe 
            180                 185                 190         


Gly Phe Arg His Leu Leu Pro Leu Thr Asp Arg Val Asp Ser Phe Asn 
        195                 200                 205             


Glu Glu Val Arg Lys Gln Arg Val Ser Arg Asn Arg Asp Ala Pro Glu 
    210                 215                 220                 


Gly Gly Phe Asp Ala Val Leu Gln Ala Ala Val Cys Lys Glu Lys Ile 
225                 230                 235                 240 


Gly Trp Arg Lys Asp Ala Leu His Leu Leu Val Phe Thr Thr Asp Asp 
                245                 250                 255     


Val Pro His Ile Ala Leu Asp Gly Lys Leu Gly Gly Leu Val Gln Pro 
            260                 265                 270         


His Asp Gly Gln Cys His Leu Asn Glu Ala Asn Glu Tyr Thr Ala Ser 
        275                 280                 285             


Asn Gln Met Asp Tyr Pro Ser Leu Ala Leu Leu Gly Glu Lys Leu Ala 
    290                 295                 300                 


Glu Asn Asn Ile Asn Leu Ile Phe Ala Val Thr Lys Asn His Tyr Met 
305                 310                 315                 320 


Leu Tyr Lys Asn Phe Thr Ala Leu Ile Pro Gly Thr Thr Val Glu Ile 
                325                 330                 335     


Leu Asp Gly Asp Ser Lys Asn Ile Ile Gln Leu Ile Ile Asn Ala Tyr 
            340                 345                 350         


Asn Ser Ile Arg Ser Lys Val Glu Leu Ser Val Trp Asp Gln Pro Glu 
        355                 360                 365             


Asp Leu Asn Leu Phe Phe Thr Ala Thr Cys Gln Asp Gly Val Ser Tyr 
    370                 375                 380                 


Pro Gly Gln Arg Lys Cys Glu Gly Leu Lys Ile Gly Asp Thr Ala Ser 
385                 390                 395                 400 


Phe Glu Val Ser Leu Glu Ala Arg Ser Cys Pro Ser Arg His Thr Glu 
                405                 410                 415     


His Val Phe Ala Leu Arg Pro Val Gly Phe Arg Asp Ser Leu Glu Val 
            420                 425                 430         


Gly Val Thr Tyr Asn Cys Thr Cys Gly Cys Ser Val Gly Leu Glu Pro 
        435                 440                 445             


Asn Ser Ala Arg Cys Asn Gly Ser Gly Thr Tyr Val Cys Gly Leu Cys 
    450                 455                 460                 


Glu Cys Ser Pro Gly Tyr Leu Gly Thr Arg Cys Glu Cys Gln Asp Gly 
465                 470                 475                 480 


Glu Asn Gln Ser Val Tyr Gln Asn Leu Cys Arg Glu Ala Glu Gly Lys 
                485                 490                 495     


Pro Leu Cys Ser Gly Arg Gly Asp Cys Ser Cys Asn Gln Cys Ser Cys 
            500                 505                 510         


Phe Glu Ser Glu Phe Gly Lys Ile Tyr Gly Pro Phe Cys Glu Cys Asp 
        515                 520                 525             


Asn Phe Ser Cys Ala Arg Asn Lys Gly Val Leu Cys Ser Gly His Gly 
    530                 535                 540                 


Glu Cys His Cys Gly Glu Cys Lys Cys His Ala Gly Tyr Ile Gly Asp 
545                 550                 555                 560 


Asn Cys Asn Cys Ser Thr Asp Ile Ser Thr Cys Arg Gly Arg Asp Gly 
                565                 570                 575     


Gln Ile Cys Ser Glu Arg Gly His Cys Leu Cys Gly Gln Cys Gln Cys 
            580                 585                 590         


Thr Glu Pro Gly Ala Phe Gly Glu Met Cys Glu Lys Cys Pro Thr Cys 
        595                 600                 605             


Pro Asp Ala Cys Ser Thr Lys Arg Asp Cys Val Glu Cys Leu Leu Leu 
    610                 615                 620                 


His Ser Gly Lys Pro Asp Asn Gln Thr Cys His Ser Leu Cys Arg Asp 
625                 630                 635                 640 


Glu Val Ile Thr Trp Val Asp Thr Ile Val Lys Asp Asp Gln Glu Ala 
                645                 650                 655     


Val Leu Cys Phe Tyr Lys Thr Ala Lys Asp Cys Val Met Met Phe Thr 
            660                 665                 670         


Tyr Val Glu Leu Pro Ser Gly Lys Ser Asn Leu Thr Val Leu Arg Glu 
        675                 680                 685             


Pro Glu Cys Gly Asn Thr Pro Asn Ala Met Thr Ile Leu Leu Ala Val 
    690                 695                 700                 


Val Gly Ser Ile Leu Leu Val Gly Leu Ala Leu Leu Ala Ile Trp Lys 
705                 710                 715                 720 


Leu Leu Val Thr Ile His Asp Arg Arg Glu Phe Ala Lys Phe Gln Ser 
                725                 730                 735     


Glu Arg Ser Arg Ala Arg Tyr Glu Met Ala Ser Asn Pro Leu Tyr Arg 
            740                 745                 750         


Lys Pro Ile Ser Thr His Thr Val Asp Phe Thr Phe Asn Lys Phe Asn 
        755                 760                 765             


Lys Ser Tyr Asn Gly Thr Val Asp 
    770                 775     


<210>  17
<211>  767
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<223>  Beta 6 integrin (GenBank Accession No. NP_000879.2)

<400>  17

Gly Cys Ala Leu Gly Gly Ala Glu Thr Cys Glu Asp Cys Leu Leu Ile 
1               5                   10                  15      


Gly Pro Gln Cys Ala Trp Cys Ala Gln Glu Asn Phe Thr His Pro Ser 
            20                  25                  30          


Gly Val Gly Glu Arg Cys Asp Thr Pro Ala Asn Leu Leu Ala Lys Gly 
        35                  40                  45              


Cys Gln Leu Asn Phe Ile Glu Asn Pro Val Ser Gln Val Glu Ile Leu 
    50                  55                  60                  


Lys Asn Lys Pro Leu Ser Val Gly Arg Gln Lys Asn Ser Ser Asp Ile 
65                  70                  75                  80  


Val Gln Ile Ala Pro Gln Ser Leu Ile Leu Lys Leu Arg Pro Gly Gly 
                85                  90                  95      


Ala Gln Thr Leu Gln Val His Val Arg Gln Thr Glu Asp Tyr Pro Val 
            100                 105                 110         


Asp Leu Tyr Tyr Leu Met Asp Leu Ser Ala Ser Met Asp Asp Asp Leu 
        115                 120                 125             


Asn Thr Ile Lys Glu Leu Gly Ser Arg Leu Ser Lys Glu Met Ser Lys 
    130                 135                 140                 


Leu Thr Ser Asn Phe Arg Leu Gly Phe Gly Ser Phe Val Glu Lys Pro 
145                 150                 155                 160 


Val Ser Pro Phe Val Lys Thr Thr Pro Glu Glu Ile Ala Asn Pro Cys 
                165                 170                 175     


Ser Ser Ile Pro Tyr Phe Cys Leu Pro Thr Phe Gly Phe Lys His Ile 
            180                 185                 190         


Leu Pro Leu Thr Asn Asp Ala Glu Arg Phe Asn Glu Ile Val Lys Asn 
        195                 200                 205             


Gln Lys Ile Ser Ala Asn Ile Asp Thr Pro Glu Gly Gly Phe Asp Ala 
    210                 215                 220                 


Ile Met Gln Ala Ala Val Cys Lys Glu Lys Ile Gly Trp Arg Asn Asp 
225                 230                 235                 240 


Ser Leu His Leu Leu Val Phe Val Ser Asp Ala Asp Ser His Phe Gly 
                245                 250                 255     


Met Asp Ser Lys Leu Ala Gly Ile Val Ile Pro Asn Asp Gly Leu Cys 
            260                 265                 270         


His Leu Asp Ser Lys Asn Glu Tyr Ser Met Ser Thr Val Leu Glu Tyr 
        275                 280                 285             


Pro Thr Ile Gly Gln Leu Ile Asp Lys Leu Val Gln Asn Asn Val Leu 
    290                 295                 300                 


Leu Ile Phe Ala Val Thr Gln Glu Gln Val His Leu Tyr Glu Asn Tyr 
305                 310                 315                 320 


Ala Lys Leu Ile Pro Gly Ala Thr Val Gly Leu Leu Gln Lys Asp Ser 
                325                 330                 335     


Gly Asn Ile Leu Gln Leu Ile Ile Ser Ala Tyr Glu Glu Leu Arg Ser 
            340                 345                 350         


Glu Val Glu Leu Glu Val Leu Gly Asp Thr Glu Gly Leu Asn Leu Ser 
        355                 360                 365             


Phe Thr Ala Ile Cys Asn Asn Gly Thr Leu Phe Gln His Gln Lys Lys 
    370                 375                 380                 


Cys Ser His Met Lys Val Gly Asp Thr Ala Ser Phe Ser Val Thr Val 
385                 390                 395                 400 


Asn Ile Pro His Cys Glu Arg Arg Ser Arg His Ile Ile Ile Lys Pro 
                405                 410                 415     


Val Gly Leu Gly Asp Ala Leu Glu Leu Leu Val Ser Pro Glu Cys Asn 
            420                 425                 430         


Cys Asp Cys Gln Lys Glu Val Glu Val Asn Ser Ser Lys Cys His His 
        435                 440                 445             


Gly Asn Gly Ser Phe Gln Cys Gly Val Cys Ala Cys His Pro Gly His 
    450                 455                 460                 


Met Gly Pro Arg Cys Glu Cys Gly Glu Asp Met Leu Ser Thr Asp Ser 
465                 470                 475                 480 


Cys Lys Glu Ala Pro Asp His Pro Ser Cys Ser Gly Arg Gly Asp Cys 
                485                 490                 495     


Tyr Cys Gly Gln Cys Ile Cys His Leu Ser Pro Tyr Gly Asn Ile Tyr 
            500                 505                 510         


Gly Pro Tyr Cys Gln Cys Asp Asn Phe Ser Cys Val Arg His Lys Gly 
        515                 520                 525             


Leu Leu Cys Gly Gly Asn Gly Asp Cys Asp Cys Gly Glu Cys Val Cys 
    530                 535                 540                 


Arg Ser Gly Trp Thr Gly Glu Tyr Cys Asn Cys Thr Thr Ser Thr Asp 
545                 550                 555                 560 


Ser Cys Val Ser Glu Asp Gly Val Leu Cys Ser Gly Arg Gly Asp Cys 
                565                 570                 575     


Val Cys Gly Lys Cys Val Cys Thr Asn Pro Gly Ala Ser Gly Pro Thr 
            580                 585                 590         


Cys Glu Arg Cys Pro Thr Cys Gly Asp Pro Cys Asn Ser Lys Arg Ser 
        595                 600                 605             


Cys Ile Glu Cys His Leu Ser Ala Ala Gly Gln Ala Arg Glu Glu Cys 
    610                 615                 620                 


Val Asp Lys Cys Lys Leu Ala Gly Ala Thr Ile Ser Glu Glu Glu Asp 
625                 630                 635                 640 


Phe Ser Lys Asp Gly Ser Val Ser Cys Ser Leu Gln Gly Glu Asn Glu 
                645                 650                 655     


Cys Leu Ile Thr Phe Leu Ile Thr Thr Asp Asn Glu Gly Lys Thr Ile 
            660                 665                 670         


Ile His Ser Ile Asn Glu Lys Asp Cys Pro Lys Pro Pro Asn Ile Pro 
        675                 680                 685             


Met Ile Met Leu Gly Val Ser Leu Ala Ile Leu Leu Ile Gly Val Val 
    690                 695                 700                 


Leu Leu Cys Ile Trp Lys Leu Leu Val Ser Phe His Asp Arg Lys Glu 
705                 710                 715                 720 


Val Ala Lys Phe Glu Ala Glu Arg Ser Lys Ala Lys Trp Gln Thr Gly 
                725                 730                 735     


Thr Asn Pro Leu Tyr Arg Gly Ser Thr Ser Thr Phe Lys Asn Val Thr 
            740                 745                 750         


Tyr Lys His Arg Glu Lys Gln Lys Val Asp Leu Ser Thr Asp Cys Gly 
        755                 760                 765         1   


Cys Ala Leu Gly Gly Ala Glu Thr Cys Glu Asp Cys Leu Leu Ile Gly 
            5                   10                  15          


Pro Gln Cys Ala Trp Cys Ala Gln Glu Asn Phe Thr His Pro Ser Gly 
        20                  25                  30              


Val Gly Glu Arg Cys Asp Thr Pro Ala Asn Leu Leu Ala Lys Gly Cys 
    35                  40                  45                  


Gln Leu Asn Phe Ile Glu Asn Pro Val Ser Gln Val Glu Ile Leu Lys 
50                  55                  60                  65  


Asn Lys Pro Leu Ser Val Gly Arg Gln Lys Asn Ser Ser Asp Ile Val 
                70                  75                  80      


Gln Ile Ala Pro Gln Ser Leu Ile Leu Lys Leu Arg Pro Gly Gly Ala 
            85                  90                  95          


Gln Thr Leu Gln Val His Val Arg Gln Thr Glu Asp Tyr Pro Val Asp 
        100                 105                 110             


Leu Tyr Tyr Leu Met Asp Leu Ser Ala Ser Met Asp Asp Asp Leu Asn 
    115                 120                 125                 


Thr Ile Lys Glu Leu Gly Ser Arg Leu Ser Lys Glu Met Ser Lys Leu 
130                 135                 140                 145 


Thr Ser Asn Phe Arg Leu Gly Phe Gly Ser Phe Val Glu Lys Pro Val 
                150                 155                 160     


Ser Pro Phe Val Lys Thr Thr Pro Glu Glu Ile Ala Asn Pro Cys Ser 
            165                 170                 175         


Ser Ile Pro Tyr Phe Cys Leu Pro Thr Phe Gly Phe Lys His Ile Leu 
        180                 185                 190             


Pro Leu Thr Asn Asp Ala Glu Arg Phe Asn Glu Ile Val Lys Asn Gln 
    195                 200                 205                 


Lys Ile Ser Ala Asn Ile Asp Thr Pro Glu Gly Gly Phe Asp Ala Ile 
210                 215                 220                 225 


Met Gln Ala Ala Val Cys Lys Glu Lys Ile Gly Trp Arg Asn Asp Ser 
                230                 235                 240     


Leu His Leu Leu Val Phe Val Ser Asp Ala Asp Ser His Phe Gly Met 
            245                 250                 255         


Asp Ser Lys Leu Ala Gly Ile Val Ile Pro Asn Asp Gly Leu Cys His 
        260                 265                 270             


Leu Asp Ser Lys Asn Glu Tyr Ser Met Ser Thr Val Leu Glu Tyr Pro 
    275                 280                 285                 


Thr Ile Gly Gln Leu Ile Asp Lys Leu Val Gln Asn Asn Val Leu Leu 
290                 295                 300                 305 


Ile Phe Ala Val Thr Gln Glu Gln Val His Leu Tyr Glu Asn Tyr Ala 
                310                 315                 320     


Lys Leu Ile Pro Gly Ala Thr Val Gly Leu Leu Gln Lys Asp Ser Gly 
            325                 330                 335         


Asn Ile Leu Gln Leu Ile Ile Ser Ala Tyr Glu Glu Leu Arg Ser Glu 
        340                 345                 350             


Val Glu Leu Glu Val Leu Gly Asp Thr Glu Gly Leu Asn Leu Ser Phe 
    355                 360                 365                 


Thr Ala Ile Cys Asn Asn Gly Thr Leu Phe Gln His Gln Lys Lys Cys 
370                 375                 380                 385 


Ser His Met Lys Val Gly Asp Thr Ala Ser Phe Ser Val Thr Val Asn 
                390                 395                 400     


Ile Pro His Cys Glu Arg Arg Ser Arg His Ile Ile Ile Lys Pro Val 
            405                 410                 415         


Gly Leu Gly Asp Ala Leu Glu Leu Leu Val Ser Pro Glu Cys Asn Cys 
        420                 425                 430             


Asp Cys Gln Lys Glu Val Glu Val Asn Ser Ser Lys Cys His His Gly 
    435                 440                 445                 


Asn Gly Ser Phe Gln Cys Gly Val Cys Ala Cys His Pro Gly His Met 
450                 455                 460                 465 


Gly Pro Arg Cys Glu Cys Gly Glu Asp Met Leu Ser Thr Asp Ser Cys 
                470                 475                 480     


Lys Glu Ala Pro Asp His Pro Ser Cys Ser Gly Arg Gly Asp Cys Tyr 
            485                 490                 495         


Cys Gly Gln Cys Ile Cys His Leu Ser Pro Tyr Gly Asn Ile Tyr Gly 
        500                 505                 510             


Pro Tyr Cys Gln Cys Asp Asn Phe Ser Cys Val Arg His Lys Gly Leu 
    515                 520                 525                 


Leu Cys Gly Gly Asn Gly Asp Cys Asp Cys Gly Glu Cys Val Cys Arg 
530                 535                 540                 545 


Ser Gly Trp Thr Gly Glu Tyr Cys Asn Cys Thr Thr Ser Thr Asp Ser 
                550                 555                 560     


Cys Val Ser Glu Asp Gly Val Leu Cys Ser Gly Arg Gly Asp Cys Val 
            565                 570                 575         


Cys Gly Lys Cys Val Cys Thr Asn Pro Gly Ala Ser Gly Pro Thr Cys 
        580                 585                 590             


Glu Arg Cys Pro Thr Cys Gly Asp Pro Cys Asn Ser Lys Arg Ser Cys 
    595                 600                 605                 


Ile Glu Cys His Leu Ser Ala Ala Gly Gln Ala Arg Glu Glu Cys Val 
610                 615                 620                 625 


Asp Lys Cys Lys Leu Ala Gly Ala Thr Ile Ser Glu Glu Glu Asp Phe 
                630                 635                 640     


Ser Lys Asp Gly Ser Val Ser Cys Ser Leu Gln Gly Glu Asn Glu Cys 
            645                 650                 655         


Leu Ile Thr Phe Leu Ile Thr Thr Asp Asn Glu Gly Lys Thr Ile Ile 
        660                 665                 670             


His Ser Ile Asn Glu Lys Asp Cys Pro Lys Pro Pro Asn Ile Pro Met 
    675                 680                 685                 


Ile Met Leu Gly Val Ser Leu Ala Ile Leu Leu Ile Gly Val Val Leu 
690                 695                 700                 705 


Leu Cys Ile Trp Lys Leu Leu Val Ser Phe His Asp Arg Lys Glu Val 
                710                 715                 720     


Ala Lys Phe Glu Ala Glu Arg Ser Lys Ala Lys Trp Gln Thr Gly Thr 
            725                 730                 735         


Asn Pro Leu Tyr Arg Gly Ser Thr Ser Thr Phe Lys Asn Val Thr Tyr 
        740                 745                 750             


Lys His Arg Glu Lys Gln Lys Val Asp Leu Ser Thr Asp Cys 
    755                 760                 765         


<210>  18
<211>  779
<212>  PRT
<213>  Homo sapiens


<220>
<221>  MISC_FEATURE
<223>  Beta 7 integrin (GenBank Accession No. NP_000880.1)

<400>  18

Glu Leu Asp Ala Lys Ile Pro Ser Thr Gly Asp Ala Thr Glu Trp Arg 
1               5                   10                  15      


Asn Pro His Leu Ser Met Leu Gly Ser Cys Gln Pro Ala Pro Ser Cys 
            20                  25                  30          


Gln Lys Cys Ile Leu Ser His Pro Ser Cys Ala Trp Cys Lys Gln Leu 
        35                  40                  45              


Asn Phe Thr Ala Ser Gly Glu Ala Glu Ala Arg Arg Cys Ala Arg Arg 
    50                  55                  60                  


Glu Glu Leu Leu Ala Arg Gly Cys Pro Leu Glu Glu Leu Glu Glu Pro 
65                  70                  75                  80  


Arg Gly Gln Gln Glu Val Leu Gln Asp Gln Pro Leu Ser Gln Gly Ala 
                85                  90                  95      


Arg Gly Glu Gly Ala Thr Gln Leu Ala Pro Gln Arg Val Arg Val Thr 
            100                 105                 110         


Leu Arg Pro Gly Glu Pro Gln Gln Leu Gln Val Arg Phe Leu Arg Ala 
        115                 120                 125             


Glu Gly Tyr Pro Val Asp Leu Tyr Tyr Leu Met Asp Leu Ser Tyr Ser 
    130                 135                 140                 


Met Lys Asp Asp Leu Glu Arg Val Arg Gln Leu Gly His Ala Leu Leu 
145                 150                 155                 160 


Val Arg Leu Gln Glu Val Thr His Ser Val Arg Ile Gly Phe Gly Ser 
                165                 170                 175     


Phe Val Asp Lys Thr Val Leu Pro Phe Val Ser Thr Val Pro Ser Lys 
            180                 185                 190         


Leu Arg His Pro Cys Pro Thr Arg Leu Glu Arg Cys Gln Ser Pro Phe 
        195                 200                 205             


Ser Phe His His Val Leu Ser Leu Thr Gly Asp Ala Gln Ala Phe Glu 
    210                 215                 220                 


Arg Glu Val Gly Arg Gln Ser Val Ser Gly Asn Leu Asp Ser Pro Glu 
225                 230                 235                 240 


Gly Gly Phe Asp Ala Ile Leu Gln Ala Ala Leu Cys Gln Glu Gln Ile 
                245                 250                 255     


Gly Trp Arg Asn Val Ser Arg Leu Leu Val Phe Thr Ser Asp Asp Thr 
            260                 265                 270         


Phe His Thr Ala Gly Asp Gly Lys Leu Gly Gly Ile Phe Met Pro Ser 
        275                 280                 285             


Asp Gly His Cys His Leu Asp Ser Asn Gly Leu Tyr Ser Arg Ser Thr 
    290                 295                 300                 


Glu Phe Asp Tyr Pro Ser Val Gly Gln Val Ala Gln Ala Leu Ser Ala 
305                 310                 315                 320 


Ala Asn Ile Gln Pro Ile Phe Ala Val Thr Ser Ala Ala Leu Pro Val 
                325                 330                 335     


Tyr Gln Glu Leu Ser Lys Leu Ile Pro Lys Ser Ala Val Gly Glu Leu 
            340                 345                 350         


Ser Glu Asp Ser Ser Asn Val Val Gln Leu Ile Met Asp Ala Tyr Asn 
        355                 360                 365             


Ser Leu Ser Ser Thr Val Thr Leu Glu His Ser Ser Leu Pro Pro Gly 
    370                 375                 380                 


Val His Ile Ser Tyr Glu Ser Gln Cys Glu Gly Pro Glu Lys Arg Glu 
385                 390                 395                 400 


Gly Lys Ala Glu Asp Arg Gly Gln Cys Asn His Val Arg Ile Asn Gln 
                405                 410                 415     


Thr Val Thr Phe Trp Val Ser Leu Gln Ala Thr His Cys Leu Pro Glu 
            420                 425                 430         


Pro His Leu Leu Arg Leu Arg Ala Leu Gly Phe Ser Glu Glu Leu Ile 
        435                 440                 445             


Val Glu Leu His Thr Leu Cys Asp Cys Asn Cys Ser Asp Thr Gln Pro 
    450                 455                 460                 


Gln Ala Pro His Cys Ser Asp Gly Gln Gly His Leu Gln Cys Gly Val 
465                 470                 475                 480 


Cys Ser Cys Ala Pro Gly Arg Leu Gly Arg Leu Cys Glu Cys Ser Val 
                485                 490                 495     


Ala Glu Leu Ser Ser Pro Asp Leu Glu Ser Gly Cys Arg Ala Pro Asn 
            500                 505                 510         


Gly Thr Gly Pro Leu Cys Ser Gly Lys Gly His Cys Gln Cys Gly Arg 
        515                 520                 525             


Cys Ser Cys Ser Gly Gln Ser Ser Gly His Leu Cys Glu Cys Asp Asp 
    530                 535                 540                 


Ala Ser Cys Glu Arg His Glu Gly Ile Leu Cys Gly Gly Phe Gly Arg 
545                 550                 555                 560 


Cys Gln Cys Gly Val Cys His Cys His Ala Asn Arg Thr Gly Arg Ala 
                565                 570                 575     


Cys Glu Cys Ser Gly Asp Met Asp Ser Cys Ile Ser Pro Glu Gly Gly 
            580                 585                 590         


Leu Cys Ser Gly His Gly Arg Cys Lys Cys Asn Arg Cys Gln Cys Leu 
        595                 600                 605             


Asp Gly Tyr Tyr Gly Ala Leu Cys Asp Gln Cys Pro Gly Cys Lys Thr 
    610                 615                 620                 


Pro Cys Glu Arg His Arg Asp Cys Ala Glu Cys Gly Ala Phe Arg Thr 
625                 630                 635                 640 


Gly Pro Leu Ala Thr Asn Cys Ser Thr Ala Cys Ala His Thr Asn Val 
                645                 650                 655     


Thr Leu Ala Leu Ala Pro Ile Leu Asp Asp Gly Trp Cys Lys Glu Arg 
            660                 665                 670         


Thr Leu Asp Asn Gln Leu Phe Phe Phe Leu Val Glu Asp Asp Ala Arg 
        675                 680                 685             


Gly Thr Val Val Leu Arg Val Arg Pro Gln Glu Lys Gly Ala Asp His 
    690                 695                 700                 


Thr Gln Ala Ile Val Leu Gly Cys Val Gly Gly Ile Val Ala Val Gly 
705                 710                 715                 720 


Leu Gly Leu Val Leu Ala Tyr Arg Leu Ser Val Glu Ile Tyr Asp Arg 
                725                 730                 735     


Arg Glu Tyr Ser Arg Phe Glu Lys Glu Gln Gln Gln Leu Asn Trp Lys 
            740                 745                 750         


Gln Asp Ser Asn Pro Leu Tyr Lys Ser Ala Ile Thr Thr Thr Ile Asn 
        755                 760                 765             


Pro Arg Phe Gln Glu Ala Asp Ser Pro Thr Leu 
    770                 775                 


<210>  19
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  19

Lys Phe Glu Glu Glu 
1               5   


<210>  20
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  20

Lys Phe Glu Glu Glu Arg Ala 
1               5           


<210>  21
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  21

Glu Glu Glu Arg Ala 
1               5   


<210>  22
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  22

Lys Phe Glu Glu Glu Arg Ala Arg Ala Lys Trp Asp Thr 
1               5                   10              


<210>  23
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  23

Lys Phe Glu Lys Glu 
1               5   


<210>  24
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  24

Arg Phe Glu Lys Glu 
1               5   


<210>  25
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  25

Lys Phe Glu Lys Glu Lys Met 
1               5           


<210>  26
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  26

Lys Phe Glu Lys Glu Lys Leu 
1               5           


<210>  27
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  27

Lys Phe Glu Lys Glu Gln Gln 
1               5           


<210>  28
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  28

Arg Phe Glu Lys Glu Lys Met 
1               5           


<210>  29
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  29

Arg Lys Phe Glu Lys Glu Lys Leu 
1               5               


<210>  30
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  30

Arg Phe Glu Lys Glu Gln Gln 
1               5           


<210>  31
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  31

Glu Lys Glu Lys Met 
1               5   


<210>  32
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  32

Glu Lys Glu Lys Leu 
1               5   


<210>  33
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  33

Glu Lys Glu Gln Gln 
1               5   


<210>  34
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  34

Lys Phe Glu Ala Glu 
1               5   


<210>  35
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  35

Lys Phe Glu Ala Glu Arg Ser 
1               5           


<210>  36
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  36

Glu Ala Glu Arg Ser 
1               5   


<210>  37
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  37

Lys Phe Gln Ser Glu 
1               5   


<210>  38
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  38

Lys Phe Gln Ser Glu Arg Ser 
1               5           


<210>  39
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  39

Gln Ser Glu Arg Ser 
1               5   


<210>  40
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  40

Leu Leu Ala Arg Arg Pro Thr Lys Gly Ile His Glu Tyr 
1               5                   10              


<210>  41
<211>  3
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (1)..(2)
<223>  Xaa can be any naturally occurring amino acid

<400>  41

Xaa Xaa Glu 
1           


<210>  42
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (1)..(4)
<223>  Xaa can be any naturally occurring amino acid

<400>  42

Xaa Xaa Xaa Xaa Glu 
1               5   


<210>  43
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (1)..(2)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (4)..(5)
<223>  Xaa can be any naturally occurring amino acid

<400>  43

Xaa Xaa Glu Xaa Xaa 
1               5   


<210>  44
<211>  12
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (1)..(7)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (9)..(12)
<223>  Xaa can be any naturally occurring amino acid

<400>  44

Xaa Xaa Xaa Xaa Xaa Xaa Xaa Lys Xaa Xaa Xaa Xaa 
1               5                   10          


<210>  45
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  45

Leu Leu Ala Arg Arg Pro Thr Lys Gly Ile His Glu Tyr 
1               5                   10              


<210>  46
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  amino acid at position 1 is myristoylated

<400>  46

Leu Leu Ala Arg Arg Pro Thr Lys Gly Ile His Glu Tyr 
1               5                   10              


<210>  47
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  amino acid at position 1 is myristoylated

<400>  47

Leu Ile Arg Tyr Ala Leu His Arg Pro Thr Lys Glu Gly 
1               5                   10              


<210>  48
<211>  34
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  48
cgtggatcca aactcctcat caccatccac gacc                                   34


<210>  49
<211>  34
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  49
gcgctcgagt taagtgcccc ggtacgtgat attg                                   34


<210>  50
<211>  32
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  50
gcgaattcaa gcttttaatg ataattcatg ac                                     32


<210>  51
<211>  33
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  51
gcgctcgagt cattttccct catacttcgg att                                    33


<210>  52
<211>  65
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  52
gcgggtaccg ccatggacta caaggacgac gatgacaagg cggacttcct gccgtcgcgg       60

tccgt                                                                   65


<210>  53
<211>  40
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  53
ggccggcggc cgctcactgt agcataagct gcttgaggtt                             40


<210>  54
<211>  65
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  54

Gly Gly Cys Cys Gly Gly Cys Gly Gly Cys Cys Gly Cys Thr Cys Ala 
1               5                   10                  15      


Ala Ala Thr Ala Thr Cys Thr Thr Gly Thr Thr Gly Thr Gly Ala Thr 
            20                  25                  30          


Gly Gly Ala Ala Thr Ala Thr Ala Ala Thr Cys Thr Gly Gly Thr Thr 
        35                  40                  45              


Cys Thr Cys Cys Ala Ala Gly Thr Thr Thr Ala Thr Cys Cys Ala Ala 
    50                  55                  60                  


Gly 
65  


<210>  55
<211>  40
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  55
ggccggcggc cgctcattca aagtcgtatt catggatgcc                             40


<210>  56
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  56
gtccaccttc ctgaagcag                                                    19


<210>  57
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  57
ggagatcgac aaatgcctg                                                    19


<210>  58
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  58
gaggagccga cgcttaata                                                    19


<210>  59
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  59
gtccaccttt ttaaagcag                                                    19


<210>  60
<211>  19
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  60
ggagatcgat aagtgcctg                                                    19


<210>  61
<211>  64
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  61
cggaattcgc catggactac aaggacgacg atgacaaggc ggacttcctg ccgtcgcggt       60

ccgt                                                                    64


<210>  62
<211>  36
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  62
gccgtcgact cactgtagca taagctgctt gaggtt                                 36


<210>  63
<211>  34
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  63

Gly Thr Cys Cys Ala Ala Gly Gly Ala Gly Ala Thr Cys Gly Ala Thr 
1               5                   10                  15      


Ala Ala Gly Thr Gly Cys Cys Thr Gly Thr Cys Thr Cys Gly Gly Gly 
            20                  25                  30          


Ala Ala 
        


<210>  64
<211>  34
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  64
ttcccgagac aggcacttat cgatctcctt ggac                                   34


<210>  65
<211>  34
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  65
cggcaagtcc acctttttaa agcagatgcg gatc                                   34


<210>  66
<211>  34
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  66
gatccgcatc tgctttaaaa aggtggactt gccg                                   34


<210>  67
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  amino acid at position 1 is myristoylated

<400>  67

Lys Phe Glu Glu Glu Arg Ala Arg Ala Lys Trp Asp Thr 
1               5                   10              


<210>  68
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  amino acid at position 1 is myristoylated

<400>  68

Lys Phe Glu Glu Glu Arg Ala 
1               5           


<210>  69
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  amino acid at position 1 is myristoylated

<400>  69

Glu Glu Ala Arg Glu Arg Lys Asp Trp Ala Lys Phe Thr 
1               5                   10              


<210>  70
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  amino acid at position 1 is myristoylated

<400>  70

Glu Ala Arg Glu Lys Phe Glu 
1               5           


<210>  71
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  amino acid at position 1 is myristoylated

<400>  71

Glu Glu Ala Arg Glu 
1               5   


<210>  72
<211>  49
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  72
gcgaagcttg ccgccatgga ccgagcgcgg ccgcggcccc ggccgctct                   49


<210>  73
<211>  45
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  73
gcgctcgagt caagcgaatt cttttcggtc gtggatggtg atgag                       45


<210>  74
<211>  45
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  74
gcgctcgagt caccagatga gcagggcggc aaggccaatg agcag                       45


<210>  75
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  75
aagaattcgc taaatttgca gaagaacgcg ccagagcaa                              39


<210>  76
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  76
aagaattcgc taaatttgag gcagaacgcg ccagagcaa                              39


<210>  77
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  77
aagaattcgc taaatttgag gaagcacgcg ccagagcaa                              39


<210>  78
<211>  39
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  78
aagaattcgc taaatttgca gcagcacgcg ccagagcaa                              39


<210>  79
<211>  49
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  79
ccgcaattgg ccgccatgga ccgagcgcgg ccgcggcccc ggccgctct                   49


<210>  80
<211>  34
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic primer

<400>  80
gcgctcgagt taagtgcccc ggtacgtgat attg                                   34


<210>  81
<211>  33
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  81
cgtggatcca ttagacaggt gatactacaa tgg                                    33


<210>  82
<211>  33
<212>  DNA
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  82
gcgctcgagt tagaagttgc acctgaaagt ttc                                    33


<210>  83
<211>  20
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide

<400>  83

His Asp Arg Lys Glu Phe Ala Lys Phe Glu Glu Glu Arg Ala Arg Ala 
1               5                   10                  15      


Lys Trp Asp Thr 
            20  


<210>  84
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  84

Phe Glu Glu Glu Arg 
1               5   


<210>  85
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  85

Ala Lys Phe Glu Glu Glu 
1               5       


<210>  86
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  86

Lys Phe Glu Glu Glu Arg 
1               5       


<210>  87
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  87

Phe Glu Glu Glu Arg Ala 
1               5       


<210>  88
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  88

Glu Glu Glu Arg Ala Arg 
1               5       


<210>  89
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  89

Glu Glu Glu Arg Ala Arg Ala 
1               5           


<210>  90
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  90

Glu Glu Glu Arg Ala Arg Ala Lys 
1               5               


<210>  91
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  91

Glu Arg Ala Phe Glu Glu 
1               5       


<210>  92
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide

<400>  92

Arg Gly Asp Ser 
1               


<210>  93
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  93

Glu Xaa Glu 
1           


<210>  94
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<400>  94

Phe Glu Xaa Glu 
1               


<210>  95
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Lys Arg or Gln

<400>  95

Phe Glu Xaa Glu Xaa 
1               5   


<210>  96
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is Lys, Arg or Gln

<400>  96

Glu Xaa Glu Xaa 
1               


<210>  97
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  97

Xaa Phe Glu Xaa Glu 
1               5   


<210>  98
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Lys, Arg or Gln

<400>  98

Xaa Phe Glu Xaa Glu Xaa 
1               5       


<210>  99
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Lys, Arg or Gln

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is any amino acid - optionally Met, Ala, Leu, Ser or Gln

<400>  99

Xaa Phe Glu Xaa Glu Xaa Xaa 
1               5           


<210>  100
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  100

Lys Phe Glu Xaa Glu 
1               5   


<210>  101
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  101

Lys Phe Glu Xaa Glu Arg Ala 
1               5           


<210>  102
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  102

Glu Xaa Glu Arg Ala 
1               5   


<210>  103
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  103

Lys Phe Glu Xaa Glu Arg Ala Arg Ala Lys Trp Asp Thr 
1               5                   10              


<210>  104
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amimo acid

<400>  104

Arg Phe Glu Xaa Glu 
1               5   


<210>  105
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  105

Lys Phe Glu Xaa Glu Lys Met 
1               5           


<210>  106
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  106

Lys Phe Glu Xaa Glu Lys Leu 
1               5           


<210>  107
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  107

Lys Phe Glu Xaa Glu Gln Gln 
1               5           


<210>  108
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  108

Arg Phe Glu Xaa Glu Lys Met 
1               5           


<210>  109
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is any amino acid

<400>  109

Arg Lys Phe Glu Xaa Glu Lys Leu 
1               5               


<210>  110
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  110

Arg Phe Glu Xaa Glu Gln Gln 
1               5           


<210>  111
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  111

Glu Xaa Glu Lys Met 
1               5   


<210>  112
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  112

Glu Xaa Glu Lys Leu 
1               5   


<210>  113
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  113

Glu Xaa Glu Gln Gln 
1               5   


<210>  114
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  114

Lys Phe Glu Xaa Glu Arg Ser 
1               5           


<210>  115
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  115

Glu Xaa Glu Arg Ser 
1               5   


<210>  116
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<400>  116

Phe Glu Xaa Glu Arg 
1               5   


<210>  117
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is any amino acid

<400>  117

Ala Lys Phe Glu Xaa Glu 
1               5       


<210>  118
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  118

Lys Phe Glu Xaa Glu Arg 
1               5       


<210>  119
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<400>  119

Phe Glu Xaa Glu Arg Ala 
1               5       


<210>  120
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  120

Glu Xaa Glu Arg Ala Arg 
1               5       


<210>  121
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  121

Glu Xaa Glu Arg Ala Arg Ala 
1               5           


<210>  122
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  122

Glu Xaa Glu Arg Ala Arg Ala Lys 
1               5               


<210>  123
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  123

Lys Phe Glu Glu Glu 
1               5   


<210>  124
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  124

Lys Phe Glu Glu Glu Arg Ala 
1               5           


<210>  125
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  125

Glu Glu Glu Arg Ala 
1               5   


<210>  126
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  126

Lys Phe Glu Glu Glu Arg Ala Arg Ala Lys Trp Asp Thr 
1               5                   10              


<210>  127
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  127

Lys Phe Glu Lys Glu 
1               5   


<210>  128
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  128

Arg Phe Glu Lys Glu 
1               5   


<210>  129
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  129

Lys Phe Glu Lys Glu Lys Met 
1               5           


<210>  130
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  130

Lys Phe Glu Lys Glu Lys Leu 
1               5           


<210>  131
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  131

Lys Phe Glu Lys Glu Gln Gln 
1               5           


<210>  132
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  132

Arg Phe Glu Lys Glu Lys Met 
1               5           


<210>  133
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  133

Arg Lys Phe Glu Lys Glu Lys Leu 
1               5               


<210>  134
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  134

Arg Phe Glu Lys Glu Gln Gln 
1               5           


<210>  135
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  135

Glu Lys Glu Lys Met 
1               5   


<210>  136
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  136

Glu Lys Glu Lys Leu 
1               5   


<210>  137
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  137

Glu Lys Glu Gln Gln 
1               5   


<210>  138
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  138

Lys Phe Glu Ala Glu 
1               5   


<210>  139
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  139

Lys Phe Glu Ala Glu Arg Ser 
1               5           


<210>  140
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  140

Glu Ala Glu Arg Ser 
1               5   


<210>  141
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  141

Lys Phe Gln Ser Glu 
1               5   


<210>  142
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  142

Lys Phe Gln Ser Glu Arg Ser 
1               5           


<210>  143
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  143

Gln Ser Glu Arg Ser 
1               5   


<210>  144
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  144

Phe Glu Glu Glu Arg 
1               5   


<210>  145
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  145

Ala Lys Phe Glu Glu Glu 
1               5       


<210>  146
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  146

Lys Phe Glu Glu Glu Arg 
1               5       


<210>  147
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  147

Phe Glu Glu Glu Arg Ala 
1               5       


<210>  148
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  148

Glu Glu Glu Arg Ala Arg 
1               5       


<210>  149
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  149

Glu Glu Glu Arg Ala Arg Ala 
1               5           


<210>  150
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<400>  150

Glu Glu Glu Arg Ala Arg Ala Lys 
1               5               


<210>  151
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  151

Glu Xaa Glu 
1           


<210>  152
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<400>  152

Phe Glu Xaa Glu 
1               


<210>  153
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Lys Arg or Gln

<400>  153

Phe Glu Xaa Glu Xaa 
1               5   


<210>  154
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is Lys, Arg or Gln

<400>  154

Glu Xaa Glu Xaa 
1               


<210>  155
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  155

Xaa Phe Glu Xaa Glu 
1               5   


<210>  156
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Lys, Arg or Gln

<400>  156

Xaa Phe Glu Xaa Glu Xaa 
1               5       


<210>  157
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Lys, Arg or Gln

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is any amino acid - optionally Met, Ala, Leu, Ser or Gln

<400>  157

Xaa Phe Glu Xaa Glu Xaa Xaa 
1               5           


<210>  158
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  158

Lys Phe Glu Xaa Glu 
1               5   


<210>  159
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  159

Lys Phe Glu Xaa Glu Arg Ala 
1               5           


<210>  160
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  160

Glu Xaa Glu Arg Ala 
1               5   


<210>  161
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  161

Lys Phe Glu Xaa Glu Arg Ala Arg Ala Lys Trp Asp Thr 
1               5                   10              


<210>  162
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  162

Arg Phe Glu Xaa Glu 
1               5   


<210>  163
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  163

Lys Phe Glu Xaa Glu Lys Met 
1               5           


<210>  164
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  164

Lys Phe Glu Xaa Glu Lys Leu 
1               5           


<210>  165
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  165

Lys Phe Glu Xaa Glu Gln Gln 
1               5           


<210>  166
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  166

Arg Phe Glu Xaa Glu Lys Met 
1               5           


<210>  167
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is any amino acid

<400>  167

Arg Lys Phe Glu Xaa Glu Lys Leu 
1               5               


<210>  168
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  168

Arg Phe Glu Xaa Glu Gln Gln 
1               5           


<210>  169
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  169

Glu Xaa Glu Lys Met 
1               5   


<210>  170
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  170

Glu Xaa Glu Lys Leu 
1               5   


<210>  171
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  171

Glu Xaa Glu Gln Gln 
1               5   


<210>  172
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  172

Lys Phe Glu Xaa Glu Arg Ser 
1               5           


<210>  173
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  173

Glu Xaa Glu Arg Ser 
1               5   


<210>  174
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<400>  174

Phe Glu Xaa Glu Arg 
1               5   


<210>  175
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is any amino acid

<400>  175

Ala Lys Phe Glu Xaa Glu 
1               5       


<210>  176
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  176

Lys Phe Glu Xaa Glu Arg 
1               5       


<210>  177
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<400>  177

Phe Glu Xaa Glu Arg Ala 
1               5       


<210>  178
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  178

Glu Xaa Glu Arg Ala Arg 
1               5       


<210>  179
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  179

Glu Xaa Glu Arg Ala Arg Ala 
1               5           


<210>  180
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  180

Glu Xaa Glu Arg Ala Arg Ala Lys 
1               5               


<210>  181
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  181

Lys Phe Glu Glu Glu 
1               5   


<210>  182
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  182

Lys Phe Glu Glu Glu Arg Ala 
1               5           


<210>  183
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  183

Glu Glu Glu Arg Ala 
1               5   


<210>  184
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  184

Lys Phe Glu Glu Glu Arg Ala Arg Ala Lys Trp Asp Thr 
1               5                   10              


<210>  185
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  185

Lys Phe Glu Lys Glu 
1               5   


<210>  186
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  186

Arg Phe Glu Lys Glu 
1               5   


<210>  187
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  187

Lys Phe Glu Lys Glu Lys Met 
1               5           


<210>  188
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  188

Lys Phe Glu Lys Glu Lys Leu 
1               5           


<210>  189
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  189

Lys Phe Glu Lys Glu Gln Gln 
1               5           


<210>  190
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  190

Arg Phe Glu Lys Glu Lys Met 
1               5           


<210>  191
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  191

Arg Lys Phe Glu Lys Glu Lys Leu 
1               5               


<210>  192
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  192

Arg Phe Glu Lys Glu Gln Gln 
1               5           


<210>  193
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  193

Glu Lys Glu Lys Met 
1               5   


<210>  194
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  194

Glu Lys Glu Lys Leu 
1               5   


<210>  195
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  195

Glu Lys Glu Gln Gln 
1               5   


<210>  196
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  196

Lys Phe Glu Ala Glu 
1               5   


<210>  197
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  197

Lys Phe Glu Ala Glu Arg Ser 
1               5           


<210>  198
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  198

Glu Ala Glu Arg Ser 
1               5   


<210>  199
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  199

Lys Phe Gln Ser Glu 
1               5   


<210>  200
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  200

Lys Phe Gln Ser Glu Arg Ser 
1               5           


<210>  201
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  201

Gln Ser Glu Arg Ser 
1               5   


<210>  202
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  202

Phe Glu Glu Glu Arg 
1               5   


<210>  203
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  203

Ala Lys Phe Glu Glu Glu 
1               5       


<210>  204
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  204

Lys Phe Glu Glu Glu Arg 
1               5       


<210>  205
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  205

Phe Glu Glu Glu Arg Ala 
1               5       


<210>  206
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  206

Glu Glu Glu Arg Ala Arg 
1               5       


<210>  207
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  207

Glu Glu Glu Arg Ala Arg Ala 
1               5           


<210>  208
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<400>  208

Glu Glu Glu Arg Ala Arg Ala Lys 
1               5               


<210>  209
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  209

Glu Xaa Glu 
1           


<210>  210
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<400>  210

Phe Glu Xaa Glu 
1               


<210>  211
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Lys Arg or Gln

<400>  211

Phe Glu Xaa Glu Xaa 
1               5   


<210>  212
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is Lys, Arg or Gln

<400>  212

Glu Xaa Glu Xaa 
1               


<210>  213
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  213

Xaa Phe Glu Xaa Glu 
1               5   


<210>  214
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Lys, Arg or Gln

<400>  214

Xaa Phe Glu Xaa Glu Xaa 
1               5       


<210>  215
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Lys, Arg or Gln

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is any amino acid - optionally Met, Ala, Leu, Ser or Gln

<400>  215

Xaa Phe Glu Xaa Glu Xaa Xaa 
1               5           


<210>  216
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  216

Lys Phe Glu Xaa Glu 
1               5   


<210>  217
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  217

Lys Phe Glu Xaa Glu Arg Ala 
1               5           


<210>  218
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  218

Glu Xaa Glu Arg Ala 
1               5   


<210>  219
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  219

Lys Phe Glu Xaa Glu Arg Ala Arg Ala Lys Trp Asp Thr 
1               5                   10              


<210>  220
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  220

Arg Phe Glu Xaa Glu 
1               5   


<210>  221
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  221

Lys Phe Glu Xaa Glu Lys Met 
1               5           


<210>  222
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  222

Lys Phe Glu Xaa Glu Lys Leu 
1               5           


<210>  223
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  223

Lys Phe Glu Xaa Glu Gln Gln 
1               5           


<210>  224
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  224

Arg Phe Glu Xaa Glu Lys Met 
1               5           


<210>  225
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is any amino acid

<400>  225

Arg Lys Phe Glu Xaa Glu Lys Leu 
1               5               


<210>  226
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  226

Arg Phe Glu Xaa Glu Gln Gln 
1               5           


<210>  227
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  227

Glu Xaa Glu Lys Met 
1               5   


<210>  228
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  228

Glu Xaa Glu Lys Leu 
1               5   


<210>  229
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  229

Glu Xaa Glu Gln Gln 
1               5   


<210>  230
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  230

Lys Phe Glu Xaa Glu Arg Ser 
1               5           


<210>  231
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  231

Glu Xaa Glu Arg Ser 
1               5   


<210>  232
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<400>  232

Phe Glu Xaa Glu Arg 
1               5   


<210>  233
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is any amino acid

<400>  233

Ala Lys Phe Glu Xaa Glu 
1               5       


<210>  234
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  234

Lys Phe Glu Xaa Glu Arg 
1               5       


<210>  235
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<400>  235

Phe Glu Xaa Glu Arg Ala 
1               5       


<210>  236
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  236

Glu Xaa Glu Arg Ala Arg 
1               5       


<210>  237
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  237

Glu Xaa Glu Arg Ala Arg Ala 
1               5           


<210>  238
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  238

Glu Xaa Glu Arg Ala Arg Ala Lys 
1               5               


<210>  239
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  239

Lys Phe Glu Glu Glu 
1               5   


<210>  240
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  240

Lys Phe Glu Glu Glu Arg Ala 
1               5           


<210>  241
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  241

Glu Glu Glu Arg Ala 
1               5   


<210>  242
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  242

Lys Phe Glu Glu Glu Arg Ala Arg Ala Lys Trp Asp Thr 
1               5                   10              


<210>  243
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  243

Lys Phe Glu Lys Glu 
1               5   


<210>  244
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  244

Arg Phe Glu Lys Glu 
1               5   


<210>  245
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  245

Lys Phe Glu Lys Glu Lys Met 
1               5           


<210>  246
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  246

Lys Phe Glu Lys Glu Lys Leu 
1               5           


<210>  247
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  247

Lys Phe Glu Lys Glu Gln Gln 
1               5           


<210>  248
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  248

Arg Phe Glu Lys Glu Lys Met 
1               5           


<210>  249
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  249

Arg Lys Phe Glu Lys Glu Lys Leu 
1               5               


<210>  250
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  250

Arg Phe Glu Lys Glu Gln Gln 
1               5           


<210>  251
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  251

Glu Lys Glu Lys Met 
1               5   


<210>  252
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  252

Glu Lys Glu Lys Leu 
1               5   


<210>  253
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  253

Glu Lys Glu Gln Gln 
1               5   


<210>  254
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  254

Lys Phe Glu Ala Glu 
1               5   


<210>  255
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  255

Lys Phe Glu Ala Glu Arg Ser 
1               5           


<210>  256
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  256

Glu Ala Glu Arg Ser 
1               5   


<210>  257
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  257

Lys Phe Gln Ser Glu 
1               5   


<210>  258
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  258

Lys Phe Gln Ser Glu Arg Ser 
1               5           


<210>  259
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  259

Gln Ser Glu Arg Ser 
1               5   


<210>  260
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  260

Phe Glu Glu Glu Arg 
1               5   


<210>  261
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  261

Ala Lys Phe Glu Glu Glu 
1               5       


<210>  262
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  262

Lys Phe Glu Glu Glu Arg 
1               5       


<210>  263
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  263

Phe Glu Glu Glu Arg Ala 
1               5       


<210>  264
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  264

Glu Glu Glu Arg Ala Arg 
1               5       


<210>  265
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  265

Glu Glu Glu Arg Ala Arg Ala 
1               5           


<210>  266
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<400>  266

Glu Glu Glu Arg Ala Arg Ala Lys 
1               5               


<210>  267
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  267

Glu Xaa Glu 
1           


<210>  268
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<400>  268

Phe Glu Xaa Glu 
1               


<210>  269
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Lys Arg or Gln

<400>  269

Phe Glu Xaa Glu Xaa 
1               5   


<210>  270
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is Lys, Arg or Gln

<400>  270

Glu Xaa Glu Xaa 
1               


<210>  271
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  271

Xaa Phe Glu Xaa Glu 
1               5   


<210>  272
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Lys, Arg or Gln

<400>  272

Xaa Phe Glu Xaa Glu Xaa 
1               5       


<210>  273
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Lys, Arg or Gln

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is any amino acid - optionally Met, Ala, Leu, Ser or Gln

<400>  273

Xaa Phe Glu Xaa Glu Xaa Xaa 
1               5           


<210>  274
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  274

Lys Phe Glu Xaa Glu 
1               5   


<210>  275
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  275

Lys Phe Glu Xaa Glu Arg Ala 
1               5           


<210>  276
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  276

Glu Xaa Glu Arg Ala 
1               5   


<210>  277
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  277

Lys Phe Glu Xaa Glu Arg Ala Arg Ala Lys Trp Asp Thr 
1               5                   10              


<210>  278
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  278

Arg Phe Glu Xaa Glu 
1               5   


<210>  279
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  279

Lys Phe Glu Xaa Glu Lys Met 
1               5           


<210>  280
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  280

Lys Phe Glu Xaa Glu Lys Leu 
1               5           


<210>  281
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  281

Lys Phe Glu Xaa Glu Gln Gln 
1               5           


<210>  282
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  282

Arg Phe Glu Xaa Glu Lys Met 
1               5           


<210>  283
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is any amino acid

<400>  283

Arg Lys Phe Glu Xaa Glu Lys Leu 
1               5               


<210>  284
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  284

Arg Phe Glu Xaa Glu Gln Gln 
1               5           


<210>  285
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  285

Glu Xaa Glu Lys Met 
1               5   


<210>  286
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  286

Glu Xaa Glu Lys Leu 
1               5   


<210>  287
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  287

Glu Xaa Glu Gln Gln 
1               5   


<210>  288
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  288

Lys Phe Glu Xaa Glu Arg Ser 
1               5           


<210>  289
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  289

Glu Xaa Glu Arg Ser 
1               5   


<210>  290
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<400>  290

Phe Glu Xaa Glu Arg 
1               5   


<210>  291
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is any amino acid

<400>  291

Ala Lys Phe Glu Xaa Glu 
1               5       


<210>  292
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  292

Lys Phe Glu Xaa Glu Arg 
1               5       


<210>  293
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<400>  293

Phe Glu Xaa Glu Arg Ala 
1               5       


<210>  294
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  294

Glu Xaa Glu Arg Ala Arg 
1               5       


<210>  295
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  295

Glu Xaa Glu Arg Ala Arg Ala 
1               5           


<210>  296
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C12-C18 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  296

Glu Xaa Glu Arg Ala Arg Ala Lys 
1               5               


<210>  297
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  297

Lys Phe Glu Glu Glu 
1               5   


<210>  298
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  298

Lys Phe Glu Glu Glu Arg Ala 
1               5           


<210>  299
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  299

Glu Glu Glu Arg Ala 
1               5   


<210>  300
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  300

Lys Phe Glu Glu Glu Arg Ala Arg Ala Lys Trp Asp Thr 
1               5                   10              


<210>  301
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  301

Lys Phe Glu Lys Glu 
1               5   


<210>  302
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  302

Arg Phe Glu Lys Glu 
1               5   


<210>  303
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  303

Lys Phe Glu Lys Glu Lys Met 
1               5           


<210>  304
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  304

Lys Phe Glu Lys Glu Lys Leu 
1               5           


<210>  305
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  305

Lys Phe Glu Lys Glu Gln Gln 
1               5           


<210>  306
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  306

Arg Phe Glu Lys Glu Lys Met 
1               5           


<210>  307
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  307

Arg Lys Phe Glu Lys Glu Lys Leu 
1               5               


<210>  308
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  308

Arg Phe Glu Lys Glu Gln Gln 
1               5           


<210>  309
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  309

Glu Lys Glu Lys Met 
1               5   


<210>  310
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  310

Glu Lys Glu Lys Leu 
1               5   


<210>  311
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  311

Glu Lys Glu Gln Gln 
1               5   


<210>  312
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  312

Lys Phe Glu Ala Glu 
1               5   


<210>  313
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  313

Lys Phe Glu Ala Glu Arg Ser 
1               5           


<210>  314
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  314

Glu Ala Glu Arg Ser 
1               5   


<210>  315
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  315

Lys Phe Gln Ser Glu 
1               5   


<210>  316
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  316

Lys Phe Gln Ser Glu Arg Ser 
1               5           


<210>  317
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  317

Gln Ser Glu Arg Ser 
1               5   


<210>  318
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  318

Phe Glu Glu Glu Arg 
1               5   


<210>  319
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  319

Ala Lys Phe Glu Glu Glu 
1               5       


<210>  320
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  320

Lys Phe Glu Glu Glu Arg 
1               5       


<210>  321
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  321

Phe Glu Glu Glu Arg Ala 
1               5       


<210>  322
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  322

Glu Glu Glu Arg Ala Arg 
1               5       


<210>  323
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  323

Glu Glu Glu Arg Ala Arg Ala 
1               5           


<210>  324
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<400>  324

Glu Glu Glu Arg Ala Arg Ala Lys 
1               5               


<210>  325
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  325

Glu Xaa Glu 
1           


<210>  326
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<400>  326

Phe Glu Xaa Glu 
1               


<210>  327
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Lys Arg or Gln

<400>  327

Phe Glu Xaa Glu Xaa 
1               5   


<210>  328
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is Lys, Arg or Gln

<400>  328

Glu Xaa Glu Xaa 
1               


<210>  329
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  329

Xaa Phe Glu Xaa Glu 
1               5   


<210>  330
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Lys, Arg or Gln

<400>  330

Xaa Phe Glu Xaa Glu Xaa 
1               5       


<210>  331
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Lys, Arg or Gln

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is any amino acid - optionally Met, Ala, Leu, Ser or Gln

<400>  331

Xaa Phe Glu Xaa Glu Xaa Xaa 
1               5           


<210>  332
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  332

Lys Phe Glu Xaa Glu 
1               5   


<210>  333
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  333

Lys Phe Glu Xaa Glu Arg Ala 
1               5           


<210>  334
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  334

Glu Xaa Glu Arg Ala 
1               5   


<210>  335
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  335

Lys Phe Glu Xaa Glu Arg Ala Arg Ala Lys Trp Asp Thr 
1               5                   10              


<210>  336
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  336

Arg Phe Glu Xaa Glu 
1               5   


<210>  337
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  337

Lys Phe Glu Xaa Glu Lys Met 
1               5           


<210>  338
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  338

Lys Phe Glu Xaa Glu Lys Leu 
1               5           


<210>  339
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  339

Lys Phe Glu Xaa Glu Gln Gln 
1               5           


<210>  340
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  340

Arg Phe Glu Xaa Glu Lys Met 
1               5           


<210>  341
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is any amino acid

<400>  341

Arg Lys Phe Glu Xaa Glu Lys Leu 
1               5               


<210>  342
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  342

Arg Phe Glu Xaa Glu Gln Gln 
1               5           


<210>  343
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  343

Glu Xaa Glu Lys Met 
1               5   


<210>  344
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  344

Glu Xaa Glu Lys Leu 
1               5   


<210>  345
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  345

Glu Xaa Glu Gln Gln 
1               5   


<210>  346
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  346

Lys Phe Glu Xaa Glu Arg Ser 
1               5           


<210>  347
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  347

Glu Xaa Glu Arg Ser 
1               5   


<210>  348
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<400>  348

Phe Glu Xaa Glu Arg 
1               5   


<210>  349
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is any amino acid

<400>  349

Ala Lys Phe Glu Xaa Glu 
1               5       


<210>  350
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  350

Lys Phe Glu Xaa Glu Arg 
1               5       


<210>  351
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<400>  351

Phe Glu Xaa Glu Arg Ala 
1               5       


<210>  352
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  352

Glu Xaa Glu Arg Ala Arg 
1               5       


<210>  353
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  353

Glu Xaa Glu Arg Ala Arg Ala 
1               5           


<210>  354
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Covalently bound to a C16 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  354

Glu Xaa Glu Arg Ala Arg Ala Lys 
1               5               


<210>  355
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  355

Lys Phe Glu Glu Glu 
1               5   


<210>  356
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  356

Lys Phe Glu Glu Glu Arg Ala 
1               5           


<210>  357
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  357

Glu Glu Glu Arg Ala 
1               5   


<210>  358
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  358

Lys Phe Glu Glu Glu Arg Ala Arg Ala Lys Trp Asp Thr 
1               5                   10              


<210>  359
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  359

Lys Phe Glu Lys Glu 
1               5   


<210>  360
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  360

Arg Phe Glu Lys Glu 
1               5   


<210>  361
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  361

Lys Phe Glu Lys Glu Lys Met 
1               5           


<210>  362
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  362

Lys Phe Glu Lys Glu Lys Leu 
1               5           


<210>  363
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  363

Lys Phe Glu Lys Glu Gln Gln 
1               5           


<210>  364
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  364

Arg Phe Glu Lys Glu Lys Met 
1               5           


<210>  365
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  365

Arg Lys Phe Glu Lys Glu Lys Leu 
1               5               


<210>  366
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  366

Arg Phe Glu Lys Glu Gln Gln 
1               5           


<210>  367
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  367

Glu Lys Glu Lys Met 
1               5   


<210>  368
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  368

Glu Lys Glu Lys Leu 
1               5   


<210>  369
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  369

Glu Lys Glu Gln Gln 
1               5   


<210>  370
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  370

Lys Phe Glu Ala Glu 
1               5   


<210>  371
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  371

Lys Phe Glu Ala Glu Arg Ser 
1               5           


<210>  372
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  372

Glu Ala Glu Arg Ser 
1               5   


<210>  373
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  373

Lys Phe Gln Ser Glu 
1               5   


<210>  374
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  374

Lys Phe Gln Ser Glu Arg Ser 
1               5           


<210>  375
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  375

Gln Ser Glu Arg Ser 
1               5   


<210>  376
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  376

Phe Glu Glu Glu Arg 
1               5   


<210>  377
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  377

Ala Lys Phe Glu Glu Glu 
1               5       


<210>  378
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  378

Lys Phe Glu Glu Glu Arg 
1               5       


<210>  379
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  379

Phe Glu Glu Glu Arg Ala 
1               5       


<210>  380
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  380

Glu Glu Glu Arg Ala Arg 
1               5       


<210>  381
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  381

Glu Glu Glu Arg Ala Arg Ala 
1               5           


<210>  382
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<400>  382

Glu Glu Glu Arg Ala Arg Ala Lys 
1               5               


<210>  383
<211>  3
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  383

Glu Xaa Glu 
1           


<210>  384
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<400>  384

Phe Glu Xaa Glu 
1               


<210>  385
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is Lys Arg or Gln

<400>  385

Phe Glu Xaa Glu Xaa 
1               5   


<210>  386
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is Lys, Arg or Gln

<400>  386

Glu Xaa Glu Xaa 
1               


<210>  387
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  387

Xaa Phe Glu Xaa Glu 
1               5   


<210>  388
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Lys, Arg or Gln

<400>  388

Xaa Phe Glu Xaa Glu Xaa 
1               5       


<210>  389
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  Xaa is Lys or Arg

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<220>
<221>  MISC_FEATURE
<222>  (6)..(6)
<223>  Xaa is Lys, Arg or Gln

<220>
<221>  MISC_FEATURE
<222>  (7)..(7)
<223>  Xaa is any amino acid - optionally Met, Ala, Leu, Ser or Gln

<400>  389

Xaa Phe Glu Xaa Glu Xaa Xaa 
1               5           


<210>  390
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  390

Lys Phe Glu Xaa Glu 
1               5   


<210>  391
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  391

Lys Phe Glu Xaa Glu Arg Ala 
1               5           


<210>  392
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  392

Glu Xaa Glu Arg Ala 
1               5   


<210>  393
<211>  13
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  393

Lys Phe Glu Xaa Glu Arg Ala Arg Ala Lys Trp Asp Thr 
1               5                   10              


<210>  394
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  394

Arg Phe Glu Xaa Glu 
1               5   


<210>  395
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  395

Lys Phe Glu Xaa Glu Lys Met 
1               5           


<210>  396
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  396

Lys Phe Glu Xaa Glu Lys Leu 
1               5           


<210>  397
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  397

Lys Phe Glu Xaa Glu Gln Gln 
1               5           


<210>  398
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  398

Arg Phe Glu Xaa Glu Lys Met 
1               5           


<210>  399
<211>  8
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is any amino acid

<400>  399

Arg Lys Phe Glu Xaa Glu Lys Leu 
1               5               


<210>  400
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  400

Arg Phe Glu Xaa Glu Gln Gln 
1               5           


<210>  401
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  401

Glu Xaa Glu Lys Met 
1               5   


<210>  402
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  402

Glu Xaa Glu Lys Leu 
1               5   


<210>  403
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  403

Glu Xaa Glu Gln Gln 
1               5   


<210>  404
<211>  7
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  404

Lys Phe Glu Xaa Glu Arg Ser 
1               5           


<210>  405
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  405

Glu Xaa Glu Arg Ser 
1               5   


<210>  406
<211>  5
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<400>  406

Phe Glu Xaa Glu Arg 
1               5   


<210>  407
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (5)..(5)
<223>  Xaa is any amino acid

<400>  407

Ala Lys Phe Glu Xaa Glu 
1               5       


<210>  408
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (4)..(4)
<223>  Xaa is any amino acid

<400>  408

Lys Phe Glu Xaa Glu Arg 
1               5       


<210>  409
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (3)..(3)
<223>  Xaa is any amino acid

<400>  409

Phe Glu Xaa Glu Arg Ala 
1               5       


<210>  410
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  410

Glu Xaa Glu Arg Ala Arg 
1               5       


<210>  411
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  411

Glu Xaa Glu Arg Ala Arg Ala 
1               5           


<210>  412
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<223>  Covalently bound to a C4-C30 fatty acid

<220>
<221>  MISC_FEATURE
<222>  (2)..(2)
<223>  Xaa is any amino acid

<400>  412

Glu Xaa Glu Arg Ala Arg Ala Lys 
1               5               


<210>  413
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  amino acid at position 1 is myristoylated

<400>  413

Glu Arg Ala Phe Glu Glu 
1               5       


<210>  414
<211>  5
<212>  PRT
<213>  Artificial sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  amino acid at position 1 is myristoylated

<400>  414

Glu Glu Glu Arg Ala 
1               5   


<210>  415
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  amino acid at position 1 is myristoylated

<400>  415

Phe Glu Glu Glu Arg Ala 
1               5       


<210>  416
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Synthetic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  amino acid at position 1 is myristoylated

<400>  416

Glu Arg Lys Ala Phe Glu Glu 
1               5           


